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Retinal prostheses have helped improve vision in patients blinded by photoreceptor 
degeneration. These electronic implants operate by electrically stimulating the remaining retinal 
cells. While retinal prosthesis users report improvements in light perception and performing basic 
visual tasks, their ability to perceive shapes and letters remains limited. Investigating stimulation 
strategies to reduce perceptual thresholds and create focal, non-overlapping phosphenes will 
increase the resolution of retinal prostheses and improve the overall patient outcomes. In this thesis 
I explore two main strategies for electrode-specific optimization of stimulation parameters: 1) a 
novel pulse paradigm for threshold reduction, and 2) an automated closed-loop method for 
adjusting stimulation parameters to create a focal retinal activation area.   
I combined human subject testing and computational modeling to investigate the effect of 
waveform asymmetry on perception shapes and thresholds with epiretinal stimulation. Threshold 
measurement and phosphene shape analysis was performed on four Argus II users. A 
computational model of a retinal ganglion cell (RGC) was created in the NEURON simulation 
environment to allow for a more thorough parameter testing and to gain insight into the biophysical 
mechanisms. Our human subject results suggest that asymmetric waveforms could increase 
perception probabilities compared to a standard symmetric pulse, and this effect can be intensified 
by addition of an interphase gap (IPG). Our computational model predicts that the most effective 
pulse for threshold reduction is asymmetric anodic-first stimulation with small duration ratios (≤ 
5) and long IPGs (≥ 2 ms). Phosphene shape analysis revealed no significant difference in percept 
 xix 
elongation with different pulse types. Average phosphene area was larger with asymmetric anodic-
first stimulation compared to other pulse types.  
Prosthetic vision quality is highly dependent on the capability to precisely activate target 
neurons and avoid off-target activation. However, studies show elongated and inconsistent 
responses to single electrode stimulation, indicating unintended stimulation of off-target neurons 
and electrode-specific activation patterns. While tuning stimulation parameters can transform the 
spatial RGC activity, a manual search for optimal parameters can be time consuming and tiring for 
patients. I developed a process for automatic optimization of stimulation parameters in silico, 
which involved training neural networks for quantifying the relationship between pulse parameters 
and spatial response descriptors, and a closed-loop algorithm to search for optimal parameters. 
Using this process, I was able to guide the parameter search effectively and converge to an optimal 
response within a few iterations.   
Finally, I presented a process for automatic optimization of stimulation parameters in vitro 
using calcium imaging in mouse retina. This process involved training neural networks at each 
iteration based on a few images, using an interior point algorithm to find the optimal parameters, 
and classifying the resulting calcium images with a CNN trained on previous data. Our results 
indicate that we can converge to optimal stimulation parameters that create focal RGC activity by 
sampling less than 1/3 of the parameter space. This approach can shorten the exploration time 
significantly compared to a manual search, especially when the parameter space is large. Findings 
of this project could lead to the development of a clinically applicable system for electrode-specific 
optimization of stimulation protocol, improving the overall outcome of artificial vision.  
 
 1 
Chapter 1 : Introduction 
 
1.1. Retina 
Vision is the most important and complex human sense. Major parts of the visual system 
include the eye, optic nerve, lateral geniculate nucleus, and primary visual cortex. The eye is the 
first component of this system (Fig. 1.1). Light passes through the cornea, lens, and vitreous humor 
to eventually form an image on the retina. The retina is a 200 m thick structure that lines the back 
of the eye [1]. Light passes through the inner layers of the retina, reaches the photoreceptor layer 
and through a process called phototransduction is transformed to electrical signals. These neural 
signals then travel from the outer layers towards the inner layers of the retina and are modified 
before reaching the ganglion cells. Different layers of the retina from outer to inner include: retinal 
pigment epithelium (RPE) layer, photoreceptor layer, outer nuclear layer (ONL), outer plexiform 
layer (OPL), inner nuclear layer (INL), inner plexiform layer (IPL), retinal ganglion cell layer 
(GCL), and nerve fiber layer (Fig. 1.1). RPE absorbs the scattered light for a better image quality 
and to reduce the photo-oxidative effect on cells. It also provides metabolic support to the 
photoreceptors and is involved in phagocytosis of photoreceptor outer segments. The 
photoreceptor layer consists of the outer segments of two main types of cells: rods and cones. Rods 
operate at dim light conditions and are responsible for night vision. The human retina contains 92 
million rods distributed mainly outside of the foveal region [2]. Cones are responsible for color 
vision in day light conditions. There are roughly 4.6 million cones in human retina, with the highest 
density in the foveal region. There are three types of cones in the primate retina: blue, green, and 
red cones which detect short, medium, and long wavelengths respectively. The ONL consists of 
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the cell bodies of rods and cones. The OPL is where rods and cones form synapses with bipolar 
cells and horizontal cells. The INL contains the cells bodies of bipolar, horizontal, and amacrine 
cells. The IPL contains synapses between bipolar, amacrine and RGCs. The GCL contains the cell 
bodies of ganglion cells (and displaced amacrine cells) and finally the nerve fiber layer consists of 




1.2. Retinal Degenerative Diseases 
In 2020 an estimated 49.1 million people were blind globally [3]. Photoreceptor 
degeneration is a major cause of vision loss. Retinitis pigmentosa (RP) and age-related macular 
degeneration (AMD) are two of the common retinal degenerative diseases that lead to loss of 
photoreceptor cells and eventual blindness [4], [5]. RP is progressive over many years. It causes 
Figure 1. 1. Cross section of the human eye and retina. Light travels through the cornea, pupil and lens and is 
focused on the retina. Through phototransduction, light is converted into electrical signals which pass through 
layers of the retina for pre-processing and eventually get to retinal ganglion cells. The neural signals then 
travel to the brain through the nerve fiber layer and optic nerve. Image courtesy of 
http://webvision.med.utah.edu/. 
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degeneration of rod photoreceptors in the periphery and tunnel vision in the early stages. In later 
stages, degeneration can progress to the central retina, affecting cones and the retinal pigment 
epithelium (RPE) , ultimately resulting in complete blindness. RP is estimated to affect 1.5 million 
people around the world, or 1 in 4,000 people in the United States and worldwide [6]. RP is a 
collective term used to describe inherited disorders with similar symptoms, but varying severity. 
Over 4000 distinct mutations in more than 70 genes can individually cause RP [7].  
AMD primarily affects the macula, causing degeneration of mainly cone photoreceptors 
and central vision loss. The affected area can grow larger as the disease progresses. AMD is the 
main cause of vision loss in people 50 and older, and affected 196 million people worldwide in 
2020. This number is expected to grow to 288 million by 2040 [8]. The exact cause of AMD is not 
known but it is linked to a number of risk factors including smoking, family history of the disease, 
high blood pressure, and age. Figure 1.2 demonstrates examples of vision loss for RP and AMD.  
 
1.2.1. Retinal degeneration therapies  
RP is characterized by progressive degeneration and dysfunction of the retina, mainly 
photoreceptors and RPE. Although there is no cure for RP, there are treatments that can possibly 
manage the progression of the disease or control the symptoms [9]. Vitamin and supplement 
therapy is advantageous to a limited group of RP patients. A study has shown that patients who 
AMD
Figure 1. 2. Vision loss pattern with RP and AMD. Left: normal sight. Middle: peripheral vision loss with RP. Right: central 
vision loss with AMD. Image courtesy of https://www.nei.nih.gov/ 
 4 
were taking vitamins A and E had a slower decline in their electroretinogram (ERG) measurements 
[10]. However, dietary modification is the definitive treatment for only three rare forms of RP 
[11], [12]. Gene therapy has shown some progress in treating RP patients with mutations in the 
RPE65 gene. In this method, a normal RPE65 gene is delivered in the subretinal space by 
intraocular injection. In 2017, FDA approved the first gene therapy that uses an adeno-associated 
virus (AAV) that targets RPE65, which has successfully improved functional vision in the 
recipients [13]. Stem cell transplantation is another possible therapy for RP. Transplanted cells can 
substitute the degenerated cells, or release growth factors to improve cell growth, survival, and 
function. There is an ongoing clinical trial to test the safety of transplanting fetal retinal tissue and 
retinal pigment epithelium in patients with RP.  Optogenetic therapy is another potential treatment 
for RP, aiming to induce light sensitivity to the remaining retinal cells by delivering a light-
sensitive opsin protein [14], [15]. A major barrier to optogenetic therapies is the lack of evidence 
for sufficient gene expression in non-human primate and degenerated human retina [16].  
AMD is an acquired disease of the macula characterized by neurodegeneration of the 
photoreceptors and retinal pigment epithelium. The presence of drusen – focal accumulation of 
yellow extracellular material beneath the RPE derived from incompletely digested fats and 
proteins – is the hallmark sign of AMD. Treatments for wet AMD or choroidal neovascularization 
(CNV) include photodynamic therapy (PDT) and anti-VEGF treatment [17], [18]. Dry AMD has 
no approved treatment currently. A study assessed the effectiveness of monthly intravitreal 
injection of lampalizumab for halting the progress of geographic atrophy (GA) in dry AMD 
patients [19], but the results showed that this drug was ineffective in treating GA [20].  
Electronic retinal prostheses have been effective in improving vision for patients blinded 




1.3. Retinal Prostheses 
Retinal prosthetic implants have helped partially restore vision in patients blinded by 
photoreceptor degeneration through electrically stimulating the surviving cells in the inner retina 
[21][22][23]. In epi-retinal implants the visual information is gathered by a video camera, 
transformed into electrical stimulation through a video processing unit (VPU), external and 
implanted coils, and delivered to a microelectrode array (MEA) implanted on the retinal ganglion 
cell (RGC) side of the retina. Three main types of retinal implants, named according to the position 
of implantation, are epiretinal, placed on the inner surface (RGC side) of the retina, subretinal, 
Figure 1. 3. Epiretinal prosthesis components. The camera gathers visual information and sends them to VPU 
for processing and transforming into electrical stimulation. Electrical signals are delivered to the MEA 
implanted on the retina, through external and implanted coils. (adapted from Chader et. al. 2009)      
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placed on the outer surface (photoreceptor side) of the retina, and suprachoroidal, placed between 
sclera and choroid [24].  
1.3.1. Epiretinal prostheses 
In epiretinal implants, the electrode array is positioned on the innermost layer of the retina. 
An advantage of epiretinal implants is familiarity of the surgery routine and lower risk of retinal 
detachment. Moreover, the fluid inside the vitreous cavity can help with heat dissipation (from 
electrical stimulation) and lower the thermal risks to the retina [25]. The close proximity of 
electrodes to the RGCs makes them the main target of direct stimulation. A disadvantage of this 
setting is that the nerve fiber layer is between the RGCs and electrodes in epiretinal stimulation, 
resulting in axonal stimulation and antidromic activation of off-target neurons. This can lead to 
perception of elongated percepts and a lower image resolution. However axonal activity can 
possibly be avoided by modifying stimulation parameters [26], [27]. Groups that have tested 
epiretinal implants in patients include Second Sight Medical Products (SSMP) Inc. (Sylmar, 
California USA), Intelligent Medical Implants (acquired by Pixium Vision, Paris, France), and 
EpiRet GmbH (Germany).  
Argus I and II devices have been developed by SSMP, both consisting of the elements 
mentioned above. Argus I contains 16 electrodes of 260 m and 520 m diameter, and Argus II 
contains 60 electrodes of 200 m diameter. Argus I was implanted in 6 subjects blinded by RP 
[28], [29]. All implant users reported light perception and the ability to perform visual tasks such 
as detecting and counting objects [30]. Argus II has a higher electrode density, increasing the 
theoretical resolution, and also covers a wider visual angle compared to Argus I (1119 vs. 
1010). Over 300 patients have been implanted with Argus II worldwide. The best reported 
visual acuity was improved from 20/ 3244 for Argus I to 20/ 1260 for Argus II [31], [32].  
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The Intelligent Medical Implants’ (IMI) device has similar components as the Argus 
implant, with a difference in wireless transmission. The IMI implant uses two wireless links, an 
RF transmission for power and an infrared (IR) transmission for data [33]. The IR transmitter is 
positioned in front of the eye and the IR receiver is implanted inside the eye, as part of the implant. 
This prototype contained 49 iridium oxide electrodes. Data transmission is interrupted by closing 
the eyes, mimicking the response in normally sighted people. 19 out of 20 subjects with advanced 
RP tested with the IMI implant reported light perception, and were able to distinguish between two 
phosphenes elicited by adjacent electrodes and recognize simple shapes [34]. Pixium Vision has 
further refined the implant after acquiring IMI. Their Intelligent Retinal Implant System (IRIS) II 
contains 150 electrodes and a glass-mounted visual interface. This device uses a neuromorphic 
image sensor that detects the coordinates and light intensities of changing pixels. A unique feature 
of this implant is a learning retinal encoder, which calibrates individual pixels and assigns them as 
excitatory or inhibitory, mimicking the ON/OFF pathways in the retina [35], [36]. Clinical trials 
in 10 subjects over 6 months demonstrated improvements in square localization, picture 
recognition, and direction of motion tasks.  
The EPI-RET3 implant from EpiRet GmbH differs from Argus and IRIS implants in that 
the internal components are entirely intraocular, eliminating the need for a transscleral cable and 
reducing the risk of complications. The external components include a video camera and visual 
processing unit which wirelessly transmits visual information to the internal components inside 
the eye [37]. The device allows for bidirectional stimulation and recording with microelectrodes, 
using ultrahigh-frequency-pulsed charge-controlled stimulation. This provides the possibility to 
modify stimulation protocols to deliver a more efficient stimulation based on the intrinsic activity 
of retinal neurons [38]. For clinical trials, 6 subjects were implanted with a basic 25 electrode 
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system. All patients reported pattern phosphenes with low stimulation thresholds, however, 
phosphene characteristics varied greatly between subjects [39].  
1.3.2. Subretinal prostheses 
Subretinal implants are positioned between sensory retina and the RPE, in the location 
where photoreceptors existed prior to degeneration. One rationale behind this placement is taking 
advantage of the signal processing capacity of inner retinal neurons to provide a more 
physiologically realistic form of vision. In addition, the implant is sitting closer to the target 
neurons (bipolar cells), requiring lower stimulation currents to elicit a response. However, the 
anatomical reorganization and degeneration of retinal interneurons can raise the stimulation 
thresholds [40], [41]. The surgical procedure for subretinal implants can be technically more 
challenging because of the adhesion of RPE to retina, and that surgeons are less familiar with this 
type of procedure. Leading groups that have focused on subretinal implants include the Boston 
Retinal Implant Project (BRIP), Optobionics (Naperville, IL, USA), Retina Implant AG 
(Reutlingen, Germany), and Pixium Vision.  
The BRIP implant is similar in design to Argus II, but it is implanted subretinally. This 
group is performing pre-clinical trials for a 256 channel device. A unique feature of this device 
compared to other subretinal implants is the high count 256 ceramic feedthroughs in a titanium 
case. This can support a lifetime of 5-10 years in physiological environments [42], [43].  
The Artificial Silicon Retina (ASR) developed by Optobionics was designed to use ambient 
light for retinal stimulation. The array is 2 mm wide, 25 µm thick, consisting of 5000 
microphotodiodes associated with 9 µm diameter iridium microelectrodes and functions passively 
with no external power [44]. A total of 10 patients were implanted with the ASR. This device 
demonstrated good longevity and safety and a temporary improvement in visual function [45]. 
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However, this improvement was attributed to the neurotrophic effect of the implant on the retina, 
and it was concluded that ambient light is unable to create sufficient photocurrent to stimulate an 
adequate population of neurons [44], [46], [47], [48].  
The Alpha IMS implant developed by Retina Implant AG (Reutlingen, Germany), is the 
only subretinal implant that obtained CE marking (similar to FDA approval). This system uses a 
multiphotodiode array (MPDA) containing 1500 units, with each unit having a combined 
photodiode amplifier electrode. It differs from ASR is that it uses an external power source to 
amplify the signal. 21% of implanted subjects reported very good improvements, recognizing 
unknown objects and letters, and 28% reported no benefit in daily life. 86% of subjects reported 
light perception and significant improvement in light localization. The best reported visual acuity 
was 20/546 on contrast-reversal Landolt C-ring testing. Object recognition significantly improved 
within the first 3 months of the trial and fell below significance after 6 months [49], [50].  Alpha 
AMS was the new generation of this implant with 1600 photodiodes and they have reported 
substantial improvement in its functional longevity [51]. Retina Implant AG was shut down in 
2019.  
The Photovoltaic Retinal Implant (PRIMA) produced by Pixium Vision uses a novel 
method for photovoltaic stimulation. The implant is a hexagonal chip consisting of 378 pixels with 
30 µm thickness and 2 mm width, inserted subretinally [52]. A near-infrared light source on the 
glasses sends visual information to each pixel and this photic energy is converted into electrical 
current that polarizes nearby neurons. Their preclinical results in animal models showed that the 
amplitude of the visual evoked potential (VEP) can be modulated by modifying the light intensity 
or pulse duration [53]. They also showed that by switching from cathodic-first to anodic-first 
pulses, the electrical stimulation thresholds can be reduced to a level that allow IR irradiance well 
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below the ocular safety limit while maintaining the spatial frequency [54]–[56]. Clinical trials for 
this device in 5 patients with atrophic age-related macular degeneration showed that all participants 
could perceive visual patterns with adjustable brightness. 3 subjects with optimal placement of the 
implant reported visual acuities between 20/460 and 20/550, which was 10% to 30% less than the 
expected acuity based on the electrode pitch [52].  
1.3.3. Suprachoroidal prostheses 
Suprachoroidal implants are placed between the choroid and sclera. The separation 
between the electrode and retina reduces the risks of retinal damage from surgery. In addition, the 
blood vessels in the choroid layer can dissipate the heat generated from stimulation [57], [58]. 
However, the increased distance leads to increased perceptual thresholds (higher current 
amplitudes needed for stimulation) and lower spatial resolution [59]. Main groups focusing on 
suprachoroidal implants area Bionic Vision Australia (BVA) and Japan’s Artificial Vision Project.  
The first prototype from the BVA group was a 24-channel containing 20 stimulating and 4 
return electrodes. Three subjects with advanced RP were implanted in 2012, all of which 
developed subretinal and suprachoroidal hemorrhage after the operation [60]. All patients reported 
phosphene perception, but they were variable in thresholds, character, and location [61], [62]. 
Light localization was better than chance in all subjects. Only one subject completed the visual 
acuity task and averaged 20/8397, which was significantly better than the visual acuity with the 
device off. In all cases, a fibrous tissue capsule was developed around the implant after 
explantation [63]. The BVA group is developing a 44-channel device, and a 99-channel (Phoenix-
99) device with quasi-monopolar stimulation patterns [64], [65].  
The suprachoroidal-transretinal stimulation (STS) device is being developed by the 
Artificial Vision Project in collaboration with NIDEK. Unlike other implants, the STS implant is 
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a 3D, 49 microelectrode array, with electrodes protruding from the array by 0.3 mm. Visual 
information is gathered by the camera on the glasses and processed by a computer on within the 
glasses arm. The external coil relays signal via the secondary coil to the decoder which creates a 
biphasic pulse. In a pilot study involving 2 patients with 9 electrode implants, phosphenes were 
elicited and both patients were able to identify and discriminate between objects with head 
scanning. One patient was able to detect motion and complete grasping tasks better than by chance 
[66]. Both subjects were able to walk along a white line and recognize everyday objects better than 
by chance, but this was not reproducible at every follow up visit [67]. Results demonstrated that 
subjects detected objects more accurately using artificial vision and residual natural vision together 
compared to only natural vision [68]. Overall, there are greater limitations to the suprachoroidal 
approach compared to epiretinal and subretinal approaches, however, a greater number of subjects 
are required to draw a conclusion.  
1.4. Clinical findings with Argus II prosthesis 
My dissertation involved testing patients who received the Argus II implant, thus a 
description of the history of this device is provided. The Argus II retinal prosthesis system (Second 
Sight Medical Products, Sylmar, CA, USA) is an epiretinal implant approved for use in the 
European Union and the United States [69]. This device has three internal and three external 
components. Internal components include a coil and electronics case sutured to the sclera (outside 
the eye), a ribbon cable connecting the electronics case and the array, and an epiretinal 
microelectrode array consisting of 60 electrodes with 200 m diameter and 520 m pitch. The 
external components include a video camera mounted on a pair of glasses, a visual processing unit 
(VPU), and a coil for transmitting data wirelessly to the internal coil.  
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Results from the initial acute experiments on human participants showed that perception 
thresholds in the macular region were lower than the extramacular regions, suggesting that arrays 
should be placed on the macular region [70]. Initial chronic studies (with Argus I) on 6 participants 
using a biphasic pulse showed that thresholds increase with the electrode-retina distance , but they 
do not change with electrode size (260 and 520 m) [29], [71]. Single electrode experiments have 
demonstrated that phosphene brightness and thresholds can be controlled by modifying parameters 
such as pulse duration, amplitude, and frequency [72]. Clinical studies have shown that single 
electrode stimulation can lead to perception of elongated phosphenes in epiretinal implant users 
[73], [74]. Unintended activation of off-target RGCs due to stimulation of axons of passage [26], 
[27] is identified as an important contributing factor to elongated responses and therefore lower 
resolution of the perceived image. A study on Argus II implant users showed 86% and 73% 
improvements in door finding and line tracking tasks respectively after 6 months of implantation 
compared to when the device is turned off [75], suggesting that some functional vision is provided 
through the implant. In another study participants were able to point to a bright square on a dark 
background [32]. In addition, participants have been able to discriminate letters on a monitor by 
head scanning [76]. However, patients with implants who can recognize letters take an average of 
Figure 1. 4. Components of the Argus II retinal prosthesis. A) external components including the video camera, external coil, 
and VPU. B) internal components including the receiver coil and electronic case, ribbon cable, and microelectrode array. C) 
fundus image of a subject with Argus II implant. 
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more than 40 seconds to do so [77]. These results show that although shape and letter perception 
with retinal prosthesis is possible, forming high resolution meaningful images and efficient shape 
detection in a way that is similar to natural vision is still uncertain [78].  
1.5. Current Limitations of Retinal Prostheses 
The efficacy of neural stimulation is highly dependent on the capability to precisely 
activate the target neuronal population, while avoiding stimulation of the off-target populations. 
In vitro studies have demonstrated that electrical stimulation of the retina results in activation of 
the off-target ganglion cells [79][27], where off-target is defined as RGCs whose cell bodies are 
not near the electrode.  
Clinical studies have also shown limitations in shape perception abilities of patients with 
retinal implants, confirming the in vitro results with respect to activation of RGCs outside the 
region of interest [77][80][73]. Off-target stimulation can result from a number of factors including 
unintended axonal activation [27][81], large size and low density of electrodes, electrode-retina 
distance which results in current spread [82][83][71], and spatiotemporal interactions between 
electrodes [84]. However, a computational study using rectangular electrodes with 10 µm diameter 
showed that a 50 µm electrode-retina seperation results in a more focal response compared to zero 
separation [85]. Desensitization of RGCs to repetitive stimulation is another factor that limits 
shape perception abilities of retinal implant users [86][87]. Studies have shown that a single 
electrode activation results in perception of streak-shaped responses in patients [88][73], which 
decreases the overall resolution of the implant. Stimulation of axon fibers passing under the 
electrode antidromically activates cell bodies and leads to elongated phosphenes [89]. In addition, 
phosphene shapes can be highly variable across electrodes and subjects (Fig. 1.5). Furthermore, 
activation of multiple electrodes along the same axonal tract does not result in two distinct 
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phosphenes, which can greatly hinder the image resolution. A study has demonstrated 
improvement in avoiding axonal activation using sinusoidal stimulation as it causes a larger gap 
between soma and axon thresholds [90]. Our group has shown that focal activation can be attained 
with longer pulses (> 25 ms) through stimulation of bipolar cells [27]. Another study has 
demonstrated the possibility of avoiding axonal activation using very short (< 500 us) anodic-first 
biphasic pulses [79]; however, the threshold charge densities for long pulses are generally above 
the Argus II safety limits for both chronic and acute stimulation. Very short pulses are efficient 
with respect to charge, but they use high current amplitudes which generates a high voltage that 
might go beyond the capacity of the stimulator.  
Another major problem with current retinal implants is the variable perception threshold 
both across different patients and with individual electrodes in the same patient. Multiple factors 
contribute to this variability including the morphological and functional differences between RGCs 
[1][91][92], non-uniform separation between electrodes and the retina [93][94], variations in 
blindness severity [95][96], and density and health of the surviving retinal neurons. Argus II 
stimulates with symmetric biphasic cathodic-first pulses. The cathodic phase causes a 
depolarization in cells to generate spikes, and the second phase balances the charge to reverse 
electrochemical reactions. Platinum gray coating on the electrodes has a charge injection safety 
Figure 1. 5. Phosphene drawings for three subjects. Phosphene shapes are drawn for each active electrode (red circles). Blue 
squares mark the approximate location of fovea. (Nanduri 2011, Thesis) 
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limit of 1 mC/ cm2 and 0.35 mC/ cm2 for acute and chronic stimulation respectively [97][88]. 
These limits are set by regulatory agencies and are based on historical studies of neural stimulation, 
which have determined the allowed amount of charge per phase without producing irreversible 
damage to the electrode and the tissue [98]. However, a clinical trial reported that among 30 
patients with retinal prostheses, about half of the electrodes had activation thresholds above the 
acute stimulation safety limit [99]. Even with a direct contact between the macula and electrodes, 
an average of 10% of electrodes have thresholds above the acute stimulation safety limit [97][88]. 
As a result, it is critical to investigate stimulation parameters that lower activation thresholds as it 
provides a wider range of stimulus intensities to work with in retinal implants [100] and decreases 
charge and power consumption [100][101]. 
1.6. Electrical Stimulation of the Retina  
Electrical stimulation of retina in vitro and in vivo in animal models can provide valuable 
information about the mechanisms of retinal activation. Clinical trials of retinal stimulation have 
provided mostly qualitative knowledge of retinal activation such as the shape, brightness, and size 
of phosphenes. Experiments with retinal implant users can also offer information on the current 
thresholds for inducing phosphenes. However, perceiving phosphenes is subject to inaccuracies 
such as background retinal activity, and residual retinal response to light in the environment. In 
addition, phosphene shapes and thresholds are highly variable across electrodes and patients [74], 
[102]. Non-uniform retinal degeneration [103], [104], disease stage, and variable separation 
between the electrodes and retina are some of the contributing factors to this variability [88], [105]. 
Therefore, to better understand and quantify retinal activity in response to electrical stimulation, 
it’s critical to perform in vitro and in vivo studies. Biophysical modeling of the retina has also 
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provided important information on the mechanisms of retinal activation, however, these models 
are generally simplified and do not capture the complexity of retinal circuits [106]–[108].  
1.6.1. Retinal ganglion cell response to electrical stimulation  
Retinal ganglion cells (RGC) are the inner most layer of the retina, whose axons form the 
optic nerve and travel to the visual processing centers in the brain. RGCs collect electrical signals 
from bipolar cells and amacrine cells. These visual information is integrated in RGC dendrites and 
cell body, and digitized into action potentials. Ganglion cell axons terminate in the lateral 
geniculate nucleus and superior colliculus [109], [110]. RGC responses to electrical stimulation 
can be classified as direct and indirect, based on the origin of activation. Direct activation happens 
when RGCs spike directly in response to stimulation. A common feature of direct RGC activation 
is the short latency of elicited spike, usually within 5 ms of the stimulus onset [111]–[113], [100]. 
Both subretinal and epiretinal stimulation can result in direct RGC activation. Direct activation is 
thought to initiate in the sodium channel band near the axon hillock [114]–[116]. Indirect RGC 
activation occurs when inner retinal neurons respond to electrical stimulation first and 
subsequently activate RGCs via synaptic activity. Spike latency for indirect activation is longer 
than direct activation, peaking tens of milliseconds after the onset of stimulation [117], but indirect 
responses are generally not time-locked to the stimulus [118], [119], unlike direct responses. 
Indirect responses are typically paired with short-latency (direct) RGC spikes, indicating that direct 
and network activation can occur simultaneously. Recording methods including patch clamping, 
microelectrode recording, and calcium imaging can provide valuable information on the temporal 
and spatial properties of RGC response to electrical stimulation.  
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1.7. Calcium imaging  
Calcium imaging is an optical method for measuring neuronal activity. The amount of 
intracellular calcium is an indirect measure of neural spiking. When a neuron fires, the membrane 
depolarization results in an influx of Ca2+ ions through ion channels on the membrane into the cell. 
Measuring this change in Ca2+ thus provides a tool for recording neuronal activity. Calcium 
dynamics within the neurons are generally slower than spiking rate, limiting the temporal 
resolution of calcium imaging [120], [121], [122], [123]. However, this method has proven 
effective in measuring spatial activity of RGCs. Calcium indicators include calcium dyes and 
genetically encoded calcium indicators (GECI). Oregon-Green BAPTA-1 and fluo-4 are two of 
the most prevalent calcium dyes with brightest indicators within visible wavelength. However, 
calcium dyes have several limitations such as leakage, compartmentalization, photobleaching, and 
lack of specificity.  
1.7.1. Genetically encoded calcium indicators 
GECIs overcome many of the limitations of synthetic dyes. Most GECIs contain one or 
two fluorescent molecules, a calcium binding domain, and a binding peptide. Cameleon was the 
first proposed GECI containing two GFP proteins with different emission wavelengths [124]. The 
first generation of cameleon has relatively low sensitivity of calcium for most applications [125]. 
Later generations of this indicator showed improved calcium sensitivity, however their 
performance lags behind the best synthetic dyes [126]. Development of GCaMP as a single 
wavelength sensor was a major breakthrough of calcium indicators. GCaMP contains a GFP 
fluorophore and the CaM-M13 calcium binding domain [127]. Various improvements to this 
indicator have been made through multiple generations of GCaMP variants (GCaMP1.6, 
GCaMP2, GCaMP3, GCaMP5, GCaMP6, and GCaMP7) to overcome limitations such as pH and 
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temperature sensitivity, low fluorescence intensity, and nonlinear bleaching [126]. In our previous 
studies we used GCaMP6 as the first GECI that outperformed the existing synthetic indicators in 
terms of sensitivity and kinetic speed [128]. For experiments in chapter 4 of this thesis we used 
jGCaMP7f, which has demonstrated improved detection of individual spikes, and tracking large 
populations of neurons using 2-photon and widefield imaging [129].  
1.7.2. Delivery methods for GECIs 
Intracellular expression of GECI relies on delivery of the foreign encoded DNA into target 
cells. DNA must be transported into the nucleus and translated to the consequent protein [130]. 
DNA delivery methods are categorized as viral and non-viral. Non-viral methods rely on 
transfection through mechanical, electrical, and chemical means, which can be less harmful to cells 
but also less effective than viral methods. In retina studies the most commonly used methods of 
transfection are electroporation, viral vectors, or using transgenic animals. Electroporation has 
been shown effective in transfecting RGC populations in vitro and in vivo, however with limited 
labeling of non-RGC populations [131], [132].  Transgenic animals have also been used for 
transfection of neurons with GECIs. Pvalb-2A-Cre: Ai38 is an example line with GCaMP3 
expressed in RGCs, horizontal cells, and Muller glia [133]. Generating an animal line that 
exclusively expresses calcium indicators in RGCs is challenging due to lack of a pan-ganglion-
cell-specific promoter [134]. In addition, forming a stable transgenic animal line requires multiple 
animal generations which makes it challenging to keep up with the new generations of GECIs over 
time. Viral vectors have overcome these limitations in productivity and specificity [135], [136]. 
Adeno-associated virus (AAV) vector is the most common vector used for retinal gene 
transduction [137]. AAV is a small (25 nm) non-enveloped, replication incompetent, single-
stranded DNA virus [138]. The advantages of AAV include the ability to achieve long term gene 
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expression, lack of toxicity and pathogenicity. In addition, compared to other virus vectors, AAV 
has a greater ability to target specific retinal cell populations. An AAV vector incorporating 
GCaMP5G has been able to specifically target 85% of RGCs, and this has been validated by 
retrograde tracer dye loading from the optic nerve [139].  
1.7.3. Previous calcium imaging studies 
A previous study in our group used GCaMP6f to study RGC stimulation thresholds with 
various pulse parameters. We showed that thresholds for RGC activation can be significantly 
reduced using asymmetric anodic-first stimuli with duration ratios (ratio of the anodic to cathodic 
phase duration) higher than 10, and symmetric anodic-first stimulation can avoid axonal activation, 
resulting in a more focal response shape (Fig. 1.6). However, symmetric anodic-first stimulation 
increases RGC activation thresholds due to the hyperpolarizing effect of the anodic phase. This 
Figure 1. 6. Spatial threshold maps for RGCs in response to symmetric cathodic-first and anodic-first, and asymmetric anodic-
first stimulation with different duration ratios (2, 5, 10, 20). Color bars show threshold in µm. Darker colors show lower 
thresholds and lighter colors show higher thresholds. (adapted from Chang et al. 2019) 
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hyperpolarization effect may be affecting axonal bundles more strongly compared to cell somas, 
which explains the focal RGC activity with this type of stimulation [140].  
Another study demontrated that using longer pulse widths (≥25 ms) can create focal RGC 
responses and avoid axonal activation (Fig 1.7). This is due to indirect activation of RGCs through 
bipolar cells. Bipolar cells have longer time constants than RGCs and are activated by long-
duration stimuli [90], [117], [119], [141]. They show that a 75 m diameter electrode might be the 
optimal option for the highest selectivity of RGC somas over axons. Response size did not decrease 
Figure 1. 7. RGC threshold maps for three electrode sizes and pulse widths. Corresponding calcium images for the 30 m 
electrode are shown in the bottom row. (adapted from Weitz et al. 2015) 
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with electrode diameter for electrodes smaller than 75 m, suggesting that there might be a lower 
limit to response size elicited by epiretinal stimulation [27].  
1.7. Single cell and MEA recording findings 
Patch clamp and MEA recordings from RGCs are other methods that provide insight into 
cell activation mechanisms. RGC desensitization to repetitive stimulation has been studied to 
provide a better understanding of visual percept fading [142]. Studies have found that electrical 
stimulation can cause feedback and feedforward inhibition in bipolar and ganglion cells that is 
induced by amacrine cells [143], [144]. Another study showed that some desensitization 
mechanisms are distinct from amacrine cell inhibition [87].  
1.8. Biophysical modeling of the retina  
One of the challenges for creating vision with electrical stimulation is the complexity of 
the retina. A simple grouping of cells into photoreceptor, bipolar, and RGC does not describe this 
complexity. The retina is an elaborate system of neurons connected together via synapses and gap 
junctions [145]. It consists of more than 50 types of neurons, arranged in three different neural 
layers. Although we have relatively sufficient understanding of the retinal cell types and anatomy, 
the underlying computation mechanisms of the retinal circuitry that result in high acuity vision are 
still poorly understood. Biophysical modeling of the retina allows for studying these mechanisms 
and developing a deeper understanding of retinal response dynamics. Neurons have been modeled 
with different complexities in previous studies. A single neuron can be characterized by a single-
compartment model, a block compartment model, or a morphologically realistic model. Single 
compartment models have been used to model different types of RGCs, horizontal cells, bipolar 
cells, and photoreceptors [146]–[149]. In these models, the neuron membrane is approximated by 
a capacitance in parallel with different conductors that mimic ion channels. To capture the ion 
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channel kinetics of RGCs, Fohlmeister-Coleman-Miller modified the formulation of Hodgkin-
Huxley model based on voltage clamp studies in tiger salamander RGCs [92], [150]. This model 
includes intracellular calcium dynamics as well as improved Na+ and K+ gating kinetics, to account 
for temporal spiking behaviors and provide flexibility in impulse encoding [151]. While single 
compartment models are simple and more efficient computationally, they have shortcomings in 
accurately predicting the biological behavior of RGCs due to lack of other neuronal compartments 
[152]. Block-compartment models are a good compromise between computational efficiency and 
model accuracy, as they are simplified versions of morphologically realistic models but include 
the essential anatomical compartments. The level of detail in these models depends on the specific 
study goals. Previous studies have shown that realistic RGC spiking behavior, comparable to 
electrophysiological recordings, can be achieved using only four neuronal compartments including 
soma, dendrites, thin segments, and axons [92]. Even simpler models (excluding dendrites) have 
been used to investigate axonal activation in epiretinal stimulation [153]. In this thesis, we use a 
block-compartment model of a RGC to study spiking behavior in response to asymmetric 
waveforms and interphase gaps.   
 
1.9. Data-driven modeling of the retina 
Data-driven models have the potential to provide insight into neural functions without 
relying on knowledge of biophysical and anatomical characteristics of the system under study. 
This method uses experimental data and defines linear or non-linear models that explain the 
relationship between the system’s input and output variables. Some groups have taken this 
approach to predict retinal responses to electrical stimulation [154]–[156]. This method has been 
used on a single RGC to define the spiking behavior in response to electrical stimulation [155], 
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and on a network level to predict the overall retinal response based on electric fields in the retina 
[154]. Data-driven models have also been used to predict human perception from a visual scene 
and to multi-electrode electrical stimulation with the whole array [157]. In this thesis, we use 
calcium images to create data-driven models of RGC spatial activity and predict spatial response 
shapes to a range of stimulus parameters.  
 
1.10. Motivation  
A number of studies have focused on improving the resolution and image quality of retinal 
implants. There has been studies on reducing the electrode size and increasing pixel density 
[112][158], but implementation of these arrays is currently not feasible due to a high charge density 
requirement and packaging limitations [22]. Other groups have investigated using perforated 
membranes to promote cell proximity to the implant [159], but the long-term stability of migrated 
cells has not been confirmed. It has also been demonstrated that activation patterns can be affected 
by electrode interactions during multichannel stimulation and modifying the spatiotemporal 
patterns of stimulation can improve the resolution [81][84][160][161]. However, the factors that 
contribute to response variability among patients and electrodes, raise the crucial need to 
customize electrical stimulation parameters to each electrode in order to achieve focal activation 
and target neurons in a specific pattern [95][96][162]. To address this need, one of my works in 
this dissertation sought to implement an optimization algorithm to focally activate RGCs by 
iteratively modifying pulse amplitude, and type (symmetric cathodic-first, symmetric anodic-first, 
asymmetric anodic-first). The algorithm was tested on a data-driven model of RGC spatial activity 
and in vitro on the mouse retina using calcium imaging.  
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Another limitation of epiretinal implants is the high perception thresholds. A study of 30 
patients with the Argus II retinal prosthesis demonstrated that about half of the electrodes had 
perception thresholds above the acute stimulation safety limit [99]. Those electrodes are used in 
groups with neighboring electrodes to allow for safe stimulation. This effectively creates larger 
electrodes, which further decreases the perceptual resolution. Investigating stimulation strategies 
to reduce perception thresholds has the potential to increase the resolution of retinal prostheses 
and improve the overall outcome for blind patients. In this thesis (Chapter 2), I performed human 
subject testing and computational modeling to examine the effect of pulse polarity order and 
asymmetry on perceptual thresholds and phosphene shape characteristics in Argus II patients. 
Psychophysical testing was done to determine the perecption probability using asymmetric anodic-
first (AA) stimulation and, interphase gap (IPG), both individually and in combination. We also 
performed phosphene shape analysis to study the effect of symmetric anodic-first (SA) and AA 
stimuli on the shape of phosphenes. 
As the mammalian retina is a complex system composed of more than 50 morphological 
types of neurons with different physiological functions [163][164], it is extremely difficult to 
predict the outcome of external electrical stimulation across this system. Computational modeling 
can help us better understand the statistical structure of RGC activation in response to stimulation, 
and study the effect of stimulus parameters such as pulse type, duration, and amplitude on the 
response of cells individually or in groups. Even though data-driven models do not account for the 
biophysical characteristics of cells, they have been successful in reconstructing and predicting the 
firing activity of neurons based on the spiking history [165][166]. A recent study demonstrated 
that a data-driven model of ON and OFF RGC responses to electrical stimulation can closely 
replicate the in vitro RGC activation map. The study also showed that a closed-loop algorithm can 
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identify optimal high frequency stimulation parameters for preferential activation of ON or OFF 
RGCs [167]. Recording the spatial activities of RGCs using calcium imaging allows real-time 
mapping of firing behavior in a large area [139]. The calcium imaging data that was previously 
collected in our lab [81] can provide insight into the statistical structure of spatial RGC activities. 
In Chapter 3 I developed data-driven models of spatial RGC activation in response to external 
stimulation based on the calcium imaging data. These models represented our in vitro experimental 
setup and were used as a test environment for the closed-loop optimization algorithm. 
To study the spiking behavior of retinal neurons and optimize the performance of the retinal 
prosthetic implants, several groups have performed in vitro experiments to record from neuronal 
populations [117]. MEAs have been typically used for this purpose [112][168]; although MEA-
based electrophysiology recording is appropriate for studying the temporal properties of RGC 
response, the spatial resolution is limited due to a number of factors such as the spacing between 
electrodes, the gap between RGCs and the electrodes, and the area covered by the MEA. Calcium 
imaging overcomes these limitations by allowing the recording of RGC activity in a large area 
[139]. Previous studies in our group have used an adeno-associated viral (AAV) vector to 
transduce RGCs with GCaMP5G [27] and GCaMP6f [79] from the family of genetically encoded 
calcium indicators (GECIs). Building on this prior work, I explored using the jGCaMP7f family 
with faster kinetics and higher detection sensitivity compared to the GCaMP6 family [129]. Using 
this technique, I mapped the spatial activity of RGCs via calcium imaging and modified 
stimulation parameters real-time to evoke activation in the region of interest.  
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Chapter 2 : The Effect of Waveform Asymmetry on Perception with Epiretinal Prostheses  
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2.1. Abstract 
Retinal prosthetic implants have helped improve vision in patients blinded by 
photoreceptor degeneration. Retinal implant users report improvements in light perception and 
performing visual tasks, but their ability to perceive shapres and letters is limited due to the low 
precision of retinal activation, which is exacerbated by axonal stimulation and high perceptual 
thresholds. A previous in vitro study in our lab used calcium imaging to measure the spatial activity 
of mouse retinal ganglion cells (RGCs) in response to electrical stimulation. Based on this study, 
symmetric anodic-first (SA) stimulation effectively avoided axonal activation and asymmetric 
anodic-first stimulation (AA) with duration ratios (ratio of the anodic to cathodic phase) greater 
than 10 reduced RGC activation thresholds significantly. Applying these novel stimulation 
strategies in clinic may increase perception precision and improve the overall patient outcomes. 
We combined human subject testing and computational modeling to further examine the effect of 
SA and AA stimuli on perception shapes and thresholds for epiretinal stimulation of RGCs. 
Threshold measurement in three Argus II participants indicated that AA stimulation could increase 
perception probabilities compared to a standard symmetric cathodic-first (SC) pulse, and this effect 
can be intensified by addition of an interphae gap (IPG). Our in silico RGC model predicts lower 
thresholds with AA and asymmetric cathodic-first (AC) stimuli compared to a SC pulse. This 
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effect was more pronounced at shorter pulse widths. The most effective pulse for threshold 
reduction with short pulse durations ( ≤ 0.12 ms) was AA stimulation with small duration ratios 
(≤ 5) and long IPGs (≥ 2 ms). For the 0.5 ms pulse duration, SC stimulation with IPGs longer than 
0.5 ms, or asymmetric stimuli with large duration ratios ( ≥ 20) were most effective in threshold 
reduction. Phosphene shape analysis did not reveal a significant change in percept elongation with 
SA stimulation. However, there was a significant increase in percept size (P < 0.01) with AA 
stimulation compared to the standard pulse in one participant. Including asymmetric waveform 
capability will provide more flexible options for optimization andn personalized fitting of retinal 
implants.  
2.2. Introduction  
Retinitis pigmentosa and age-related macular degeneration are prevalent retinal 
degenerative diseases that can lead to severe visual impairment or blindness [169], [170]. Retinal 
prosthetic implants have helped improve vision in people blinded by these conditions through 
electrically stimulating the remaining cells in the inner retina [21], [40], [70]. Patients with these 
implants report improvements in light perception and performing visual tasks [30], [32], [69], [75], 
[171], but their ability to perceive shapes and letters is currently limited [77], [80]. The best visual 
acuity (reported in peer-reviewed journals) is 20/1260 for epiretinal [99] and 20/460 for subretinal 
implants [52]. These acuity values do not yet demonstrate a level of restored vision that is better 
than legal blindness (20/200). 
Clinical studies have shown that single electrode activation can lead to perception of 
elongated phosphenes in epiretinal implant users [73], [74]. Unintended activation of off-target 
retinal ganglion cells (RGC) due to stimulation of axons of passage [26], [27] is identified as an 
important contributing factor to elongated responses and therefore lower precision of retinal 
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activation. A study of 30 patients with the Argus II retinal prosthesis demonstrated that about half 
of the electrodes had perception thresholds above the acute stimulation safety limit [99]. To allow 
safe stimulation, such electrodes are used in unison with neighboring electrodes, effectively 
creating a larger electrode, which further decreases the perceptual resolution. Investigating 
stimulation strategies to reduce perception thresholds and create focal phosphenes has the potential 
to increase the resolution of retinal prostheses and improve the overall outcome for blind patients.  
Our previous in vitro calcium imaging study [26] showed that asymmetric anodic-first 
stimulation with duration ratios (ratio of the anodic to cathodic phase) greater than 10 reduces 
RGC activation thresholds significantly, compared to a standard cathodic-first pulse. We also 
demonstrated that symmetric anodic-first stimulation with short durations (< 120 µs) results in a 
more focal response confined to the area near the electrode and presumably avoids stimulating 
axons of passage; however this type of stimulation also increases activation thresholds 
significantly. 
In this study, we combined human subject testing and computational modeling to further 
examine the effect of pulse polarity order and asymmetry on perceptual thresholds and phosphene 
shape characteristics in Argus II patients. Psychophysical testing was done to determine how 
probability of generating a percept was effected by use of  asymmetric anodic-first (AA) 
stimulation and, interphase gap (IPG), both individually and in combination. We also performed 
phosphene shape analysis to study the effect of symmetric anodic-first (SA) and AA stimuli on the 
shape of elicited percepts.  
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2.3. Methods  
2.3.1. Human Subject Testing 
Four eligible participants with the Argus II retinal prosthesis were recruited from the W.K. 
Kellogg Eye Center (University of Michigan, Ann Arbor, MI). Informed consent was obtained 
from each participant, following approval from the University of Michigan’s Institutional Review 
Board (IRB). The study adhered to the tenets of the Declaration of Helsinki and the national 
regulations for medical device clinical trials (Clinicaltrials.gov identifier: NCT03635645).  
Stimulation was delivered to patient implants using a research Video Processing Unit 
(VPU), controlled with the Clinician Fitting System (CFS) and the Asymmetric Waveform 
Research Tool (Second Sight Medical Products, Sylmar, CA, USA). A short pulse width (0.2 ms) 
was used for stimulation to induce direct activation of RGCs [26], [100], and to maintain the total 
pulse duration below 6 ms (Argus II limit) when applying AA stimulation. IPG was included as a 
variable, since it has been shown to reduce stimulation thresholds by delaying the opposing effect 
of the anodic phase on neural depolarization [172]. We compared its effect on threshold reduction 
with that of AA stimulation. In all experiments, 15% of the trials were catch trials randomly 
distributed among stimulus-present trials.  
2.3.2. Threshold Measurement 
Perceptual thresholds were measured for symmetric cathodic-first (SC) and SA stimuli for 
4 electrodes per participant. First, an approximate threshold range was determined for each 
electrode by applying stimuli with increasing amplitude. Within the approximate threshold range, 
10 pulse amplitudes were chosen for more thorough testing. Threshold was measured for all 4 
electrodes during one “block” of testing and each electrode had a distinct set of 10 amplitudes for 
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testing. Each trial consisted of one electrode stimulated at one amplitude with 20 identical pulses 
over 1 second. The participant was cued with an audio tone to indicate (verbally) whether or not 
they saw a percept. Responses were collected for all 4 electrodes and 10 amplitudes in random 
order, to avoid desensitzation and order effects. A logistic function was fit to the data and threshold 
was defined as the pulse amplitude corresponding to 50% probablility on the logistic curve (Fig 
2.1). 
 Asymmetric pulses use two different amplitudes but must maintain charge balance. The 
Argus II implant has a limited set of current amplitudes available. Thus, only a limited number of 
asymmetric pulse durations and amplitudes were available to use. As a result, we could not follow 
the same protocol for estimating threshold described above, since a full logistic threshold curves 
could not be generated for asymmetric pulses. Instead, perception probabilities for multiple pulse 
types were measured and compared at a single amplitude. For asymmetric pulses, amplitude refers 
to the current in the cathodic phase. For each electrode we selected an amplitude value that satisfied 
three conditions: 1) A subthreshold amplitude (between 0% and 50% probability) based on the SC 
threshold curve calculated earlier, 2) availability of that amplitude with AA stimulation, and 3) 
Figure 2. 1. Example logistic curves fitted to percept probability as a function of stimulation amplitude for electrode D06 (left) 
and C04 (right) for participant 3. Dashed line shows 50% probability of eliciting a percept. 
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availability of a duration ratio higher than 10 at that amplitude. Four stimulation types (SC, SA, 
AA, SC + IPG) were delivered with the aforementioned amplitude and repeated 20 times each in 
order to calculate the perception probabilities. Each trial consisted of a pulse train of 20 pulses in 
1 second. The active electrode and pulse type were chosen randomly in each block of trials. Based 
on our previous in vitro study [26], we hypothesized that AA pulses would have lower thresholds, 
and thus higher perception probabilities at the same amplitude. The same process was repeated (3 
electrodes per participant) to measure perception probabilities in response to SC and AA stimuli 
with different IPG values (SCI and AAI). We used paired t-tests with Bonferroni correction to 
compare different groups of perception probabilities.  
 2.3.3. Phosphene Shape Analysis 
Each trial began with a control experiment using tactile targets to calculate the participant’s 
drawing bias and variability [73]. Participants were asked to feel the tactile shapes and draw them 
on a touch-screen monitor, considering the shape, size, and orientation of the objects (Fig. 2.2). 
For retinal stimulation trials, we asked participants to draw their perceptions in response to stimuli 
consisting of a pulse train delivered at 20 Hz for a total duration of 3 seconds (Fig. 2.3). We used 
SC, SA, and AA stimuli at a single amplitude. The amplitude value had to satisfy three conditions: 
1) A suprathreshold amplitude based on the previously calculated SC threshold curve, 2) 
availability of that amplitude with AA stimulation, and 3) availability of a duration ratio higher 
than 10 at that amplitude. We chose a suprathreshold amplitude to ensure a phosphene in the 
majority of trials. Phosphene shapes were analyzed using two descriptors: area and elongation. 
Area is defined as the total number of non-zero pixels in the image, and elongation is the ratio of 
the major to minor axis of the best-fit ellipse. Inclusion of catch trials and randomization of 
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electrodes were done similarly to the threshold measurement task. Paired t-tests with Bonferroni 







Figure 2. 2. Tactile target control task. A) tactile shapes. B) participant feeling the tactile shape before drawing on the 
touch screen. 
Figure 2. 3. Phosphene drawing task. A) participant drawing a phosphene after electrical stimulation. B) example drawing of 
a phosphene. C) active electrode in this example. 
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2.3.4. Computational Modeling 
A computational model of a RGC with simplified geometry was built in the NEURON 
simulation environment [173] to study the effect of pulse asymmetry and polarity order on 
activation thresholds. This allowed us to test a more exhaustive parameter set than what was 
feasible with human subjects. The geometry and membrane kinetics were based on a previously 
published model [153] with modifications made to the length of segments. The model consisted 
of 1065 compartments of 1 µm length constructing an axon, narrow region of axon, initial segment 
of axon, and soma, with 1 mm, 45 µm, 10 µm, and 10 µm lengths respectively (Fig. 2.4). The RGC 
membrane included five nonlinear ion channels: sodium (?̅?Na), delayed rectifier potassium (?̅?K,dr), 
inactivating potassium (?̅?K,A), calcium activated potassium (?̅?K,Ca), and L-type calcium (?̅?Ca). 
The ion channel conductances varied by RGC region, as described in Schiefer et al. These were in 
parallel with a leakage conductance and a membrane capacitance. A point current source was 
placed above the axon – axon narrow region junction, at a 50 µm distance from the neuron 
vertically to simulate the thickness of the nerve fiber layer and inner limiting membrane [174]. 
The extracellular space was modeled as a purely resistive homogenous volume conductor with 500 
Ω–cm resistivity [175]. To study the effect of AA stimulation on thresholds, six different pulse 
types were used: SC, and AA with 2, 5, 10, 20, and 30 duration ratios. Pulse widths ranged from 
0.05 to 0.5 ms, and IPGs ranged from 0.1 to 2 ms.  Electrical current pulses were delivered at 20 
Hz for a total duration of 1500 ms (30 pulses). This frequency was chosen for consistency with the 
clinically used parameters. Electrcial potential at each point along the neuron was calculated using 
equation (1). 
                                           𝑉𝑒 =  
𝜌𝑒𝐼
4𝜋𝑟
                                               (1) 
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Where Ve = extracellular potential, ρe = resistivity of the extracellular space, I = electrode 
current, r = distance between the center of each compartment to the electrode. 
Numerical integration was done using a backward Euler method with a time step of 2 µs. 
Activation threshold was defined as the minimum amplitude at which the cell fired an action 
potential in response to at least 50% of the delivered pulses and calculated using a bisection 
algorithm with a ±0.1 µA error. Based on our in vitro study [26] and the human subject testing 
results, we hypothesized that AA stimulation with a large duration ratio reduced the threshold by 
the anode break excitation mechanism [176]. Differences in time constants for the m, n, and h 
gating variables are responsible for anode break excitation. After termination of a prolonged 
hyperpolarizing stimulation, the short time constant for sodium channel activation (m) leads to a 
sodium influx greater than potassium efflux, thereby increasing the probability of excitation. 
Adding a cathodic phase after termination of the anodic pulse further increases the excitation 
probability. Anode break was demonstrated in the squid giant axon, which is modeled by Hodgkin 
and Huxley using only Na+ and K+ channels. However, RGCs have at least 5 types of ion channels 





3ℎ(𝐸 − 𝐸𝑁𝑎) −  ?̅?𝐶𝑎𝑐
3(𝐸 − 𝐸𝐶𝑎) − ?̅?𝐾,𝑑𝑟𝑛
4(𝐸 − 𝐸𝐾) − ?̅?𝐾,𝐴𝑝
3𝑞(𝐸 −
𝐸𝐾) −  𝑔𝐾,𝐶𝑎(𝐸 − 𝐸𝐾) −  ?̅?𝐿(𝐸 − 𝐸𝐿) + 𝐼𝑠𝑡𝑖𝑚                                                                                                     (2)                                      
Where m, h, c, n, p, and q are the gating variables of the voltage-gated ion channels, ENa, 
ECa, EK, and EL are the equilibrium potentials of the ion channels, E is the membrane potential, 
?̅?Na, ?̅?K,dr, ?̅?K,A, ?̅?K,Ca, ?̅?Ca are the ion channel conductances, and Cm is the membrane 
capacitance. To gain insight into the mechanism of threshold reduction by AA stimulation in a 
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RGC, we analyzed the membrane voltage and the numerical values of gating variables over the 
course of stimulation. 
 
Figure 2. 4. Computational model of a single retinal ganglion cell. The geometry consists of the RGC soma, axon initial segment, 
axon narrow region, and axon. A point current source is positioned 50 µm above the axon- axon narrow region junction. Each 
compartment consists of five ion channels (Na+, delayed rectifier K+, inactivating K+, Ca2+ activated K+, and L-type Ca2+), a leak 
channel, and a membrane capacitance. (figure is not drawn to scale) 
2.4. Results 
2.4.1. Human Subject Testing 
Perception threshold and probability measurement was performed on four Argus II 
participants. One participant was removed from the analysis due to a high false positive rate (55-
70%). Results from the remaining participants were analyzed separately and are shown in figure 
(2.5). The full logistic threshold curve could not be generated for SA stimulation for participant 3, 
since the perception probability did not reach the threshold despite stimulation with the maximum 
amplitude allowable within the safety limits. For participants 1 and 2 there was an increase in 
thresholds with SA compared to SC stimulation, consistent with previous in vitro studies [26], 
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[55], [179]. This difference was significant for participant 1 (29.66% increase in average threshold, 
P < 0.05), and not significant for participant 2 (19.58% increase in average threshold). All p-values 
were adjusted by the Bonferroni correction since multiple hypotheses were being tested in each 
experiment. We demonstrated that AA stimulation and SC stimulation with an IPG increase 
perception probability significantly compared to both SC and SA stimuli in participants 1 and 2. 
Participant 3 showed no difference in perception probabilities (Fig. 2.5. A3). This might be due to 
the participant not reporting phosphenes accurately, evident from his high false positive rate on 
that day (31.67 %). Introducing an IPG to the SC pulse raised the perception probability 
significantly regardless of the IPG duration in participant 1. Perception probability increased with 
the duration of IPG in participants 2 and 3, however this change was not significant (Fig. 2.5. B2 
and B3). Adding an IPG to the AA pulse increased the perception probability in participant 1, 
however not significantly (Fig. 2.5. C1). This effect was less obvious for the other two participants 





Phosphene shape analysis revealed no significant difference between percept elongations 
in response to SA, SC, and AA stimuli. Average phosphene area was significantly larger with AA 
stimulation compared to SC (121.67% increase, P < 0.01) and larger compared to SA (64.8% 
increase) for participant 2. An increase in average phosphene area with AA stimulation was 
observed in participants 1 (38.64% increase from SC, 8.1% increase from SA) and 3 (2.39% 
increase from SC, 3.26% increase from SA), but this change was not significant. Perception 
thresholds were lower with AA stimulation, therefore with the same amplitude it is expected that 
this pulse creates larger percepts compared to symmetric pulses. Figure 2.6 and 2.7 show example 
Figure 2. 5. A1-A3) Perception probability comparison for different pulse types in human participants. Each plot represents 
perception probability values for SA, SC, AA, and SCI stimuli for 4 electrodes. False positive rates: participant 1 = 0 %, 
participant 2 = 0 %, participant 3 = 31.67 % B1-B3) Perception probability comparison for SC stimulation with different IPG 
values. Each plot represents perception probability values for SC pulse with different IPG values measured for 3 electrodes. False 
positive rates: participant 1 = 9 %, participant 2 = 0.8 %, participant 3 = 12 % C1-C3) Perception probability comparison for AA 
stimulation with different IPG values. Each plot represents perception probability values for AA pulse with different IPG values 
measured for 3 electrodes. False positive rates: participant 1 = 9 %, participant 2 = 0.8 %, participant 3 = 12 %. (P<0.05*, 
P<0.01**, P<0.001***). In some cases (plot 1B for example), the data points overlap. Black dots represent perception 
probability values for individual electrodes. Red diamonds represent the average perception probability for each column of data.   
Figure 2. 6. Example phosphene drawings for participant 3. Top and bottom row show phosphene drawing examples for asymmetric 
anodic-first pulses with 0.1 ms duration for two different electrodes. 5 similar trials were done for each electrode and drawings were 
averaged for statistical analyses. 
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drawings for participant 3 and 1 respectively in response to asymmetric anodic-first pulse train 
with 0.1 ms and 0.2 ms cathodic phase pulse width.  
 
2.4.2. Computational modeling 
A computational model of a RGC (described in 2.2) was used to further investigate the 
effect of order and duration ratio of pulse polarities on activation thresholds in epiretinal 
stimulation. The model predicts lower activation thresholds with longer IPGs, consistent with our 
human subject testing results and with previous research studies [172], [180], [181]. Our results 
reveal that the effect of IPG is more pronounced for shorter pulse widths (Fig. 2.8). Figure (2.9) 
shows the percent change in threshold with AA stimulation of different duration ratios vs. SC 
stimulation. The model predicts lower activation thresholds with higher duration ratios, consistent 
with our previous in vitro research study [26]. The threshold reduction effect is more pronounced 
with shorter pulse widths.  
Figure 2. 7. Example phosphene drawings for participant 1. Top and bottom row show phosphene drawing examples for asymmetric 
anodic-first pulses with 0.2 ms duration for two different electrodes. 5 similar trials were done for each electrode and drawings were 




Figure (2.10) shows these parameters during an anodic pulse of 2 ms and 5 µA amplitude. 
In this model, with the electrode positioned nearest the junction of axon - axon narrow region, the 
action potential initiated in the  narrow region. The sodium (Na+) and delayed rectifier  potassium 
(K+,dr) currents are dominant because the membrane conductances for other ionic currents are 
Figure 2. 8. Model predictions of percent change in activation threshold with SC stimulation with interphase gap vs. no 
interphase gap in a RGC. Effect of IPG on threshold reduction is stronger for shorter pulse widths.   
Figure 2. 9. Model predictions of percent change in activation threshold with AA vs. SC stimulation in a RGC. Effect of 
AA stimulation on threshold reduction is stronger for shorter pulse widths. 
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negligible in the axon narrow region [153], [182]. There is a reduction in the m and n values and 
an increase in the h value. These changes are more gradual for n and h, and more immediate for m 
during the anodic pulse due to their different time constants ( τm << τn , τh). After removal of the 
hyperpolarizing pulse, m rapidly returns to its normal value while h is still elevated and n is 
depressed, which promotes INa > IK and a high excitation probability. Figure 2.10.A and B were 
single pulses extracted from trains of 10 pulses. An anodic only pulse evoked an action potential 
once out of 10 pulses, while the AA pulse evoked an action potential 10 out of 10 pulses. This 
model result supports the mechanism of anode break as a means of making cells more sensitive to 
cathodic stimulation, if not exciting cells directly. 
If the action potential is generated in the initial segment of axon (axon hillock), other ionic 
currents (IK,A, ICa , and IK,Ca) also need to be studied for a comprehensive examination of RGC 
activation mechanism with AA stimulation. The long hyperpolarizing current causes a drop in m, 
n, p, and c, and an increase in h and q values. The reduction in p and elevation in q (Fig. 2.10) 
results in an overall lower IK,A and lower total potassium current according to (2).  ICa is expected 
to decrease during the hyperpolarization as c is lowered. However, the Ca2+ current has a negligible 
contribution to action potential generation and due to slower kinetics, only appears after the sodium 
channel activation has initiated the spike [147]. IK,Ca is very small compared to other ionic currents 
during an action potential and is only dominant during the early portion of the interspike interval. 
There is no independent gating variable defined for the calcium activated potassium channel and 
the change in its conductance is ligand-gated based on the internal Ca2+ concentration. The Ca2+ 
concentration is virtually constant before initiation of the spike. However, a small decrease in IK,Ca 
is expected due to the membrane hyperpolarization according to (2). After removal of the 
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hyperpolarization, sodium current begins to recover rapidly while the total potassium current is 
still lowered due to the slower kinetics of potassium channels. This makes the membrane more 
excitable.  
 
We used our model to investigate a wider range of stimulus settings than was practical in 
the human subjects. In particular, we investigated AA stimulation with different IPG values for 
comparison to human testing results, and asymmetric cathodic-first (AC), which was not tested in 
human subjects. Figure (2.11) displays the percent threshold change in response to a range of IPGs 
(0-2 ms) and pulse types (AC and AA with 2, 5, 10, 20, 30 duration ratios, and SC). The effect of 
Figure 2. 8. Membrane response to stimulation in the RGC computational model. A) Top: Membrane voltage in response to an 
anodic pulse. The cell spikes with some latency after termination of stimulation. Stimulation includes an anodic current pulse of 
2.4 ms duration and 5 µA amplitude. Bottom: Membrane gating variables before, after and during stimulation (between the 
dashed lines). Varying time constants of the gating variables results in an action potential. B) Top: Membrane voltage in 
response to an AA pulse. The cell spikes in response to the cathodic phase of the stimulus. Stimulation includes an AA current 
pulse of 2.4 ms anodic and 0.12 ms cathodic phase duration, with 5 µA anodic and 100 µA cathodic phase amplitude. Bottom: 
membrane gating variables before, after and during stimulation. Dashed lines show the limits of the anodic phase. The anodic 
only pulse evoked an action potential once out of 10 pulses, while the AA pulse evoked an action potential 10 out of 10 pulses. 
The differences in the initial values of the gating variables between A and B are due to the cumulative effect of previously 
applied pulses. 
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IPG duration on threshold with all pulse types could be described by a decaying logarithmic 
function. The effects of both IPG and asymmetric pulses on thresholds are less pronounced for 
longer pulses. 
The comparison of AA to AC pulses demonstrated that AA is more effective than AC in 
threshold reduction but only at smaller duration ratios with longer IPGs for 0.05 – 0.12 ms pulse 
widths. This indicates that the anode break mechanism is more effective at reducing thresholds 
with a higher amplitude anodic phase and a gap between the anodic and cathodic phases. This is 
in agreement with the anode break excitation mechanism (Fig. 2.10) since the gating variable 
dynamics can result in membrane excitation only with some latency after termination of the 
hyperpolarizing pulse [176]. In absence of a gap or with shorter gaps, AC is more effective than 
AA. Both reduce the threshold by applying an anodic phase with lower amplitude and longer 
duration compared to the anodic phase of symmetric pulses, reducing the inhibitory effect of the 
anodic phase. However, with AC the inhibitory phase comes after the excitatory phase. Thus, 
multiple factors appear to contribute to achieve the lowest excitation threshold. Our initial 
hypothesis that the threshold reduction effect of AA stimulation is based on the anode break 
excitation mechanism is partially supported by the results. AA pulses with small duration ratios (≤ 
5) and long IPGs (≥ 2 ms), were most effective in threshold reduction for 0.05 – 0.12 ms pulse 
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widths. SC pulses with IPGs longer than 0.5 ms, and asymmetric pulses with large duration ratios 
(≥ 20) were most effective in threshold reduction for 0.5 ms pulse widths (Fig. 2.11). 
 
2.5. Discussion and Conclusion 
Our human subject testing and computational modeling of a single RGC establish that 
asymmetric anodic-first stimulation is an effective strategy to reduce stimulation thresholds in 
epiretinal stimulation and that this effect is stronger at higher duration ratios, consistent with our 
in vitro findings in mice [26]. Our computational modeling results demonstrate that this threshold 
reduction effect is more pronounced for shorter pulse widths. Even though the threshold current is 
lower with longer pulse widths, charge per phase increases with pulse width [101], [158], [168]. 
Therefore, using shorter pulses in clinic will likely be advantageous because the safety limit is 
Figure 2. 9. Model predictions of percent change in activation thresholds with different pulse types and IPGs vs. standard SC 
stimulation. A1-A4) threshold change for AA vs. SC. The x-axis for each colormap represents pulse types: SC, AA with 2, 5, 10, 20, 
and 30 duration ratios. B1-B4) threshold change for AC vs. SC. The x-axis for each colormap represents pulse types: SC, AC with 2, 
5, 10, 20, and 30 duration ratios. The y-axis represents IPG values. The color bar limits were kept constant to allow comparison 
between different pulse widths. The tiles with the highest threshold reduction percentage are outlined with a red line for each pulse 
width. The threshold reduction effects of IPG and asymmetric stimuli are less with longer pulse durations.   
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defined in terms of charge per unit area. Using short AA pulses can lower the threshold currents 
compared to a standard cathodic-first biphasic pulse, while maintaining the benefit of low charge 
per phase associated with short pulses.  
According to our computational modeling results (Fig. 2.9) and previous in vitro findings, 
AA stimulation with smaller duration ratios (≤ 5) is less effective for threshold reduction. 
However, our model which tested a combination of AA stimulation and IPG (Fig. 2.11), indicated 
that AA pulses with small duration ratios (≤ 5) and long IPGs (≥ 2 ms) are amongst the most 
effective stimuli in threshold reduction. We have previously shown that smaller duration ratios of 
AA stimulation produce focal responses, meaning the RGC response is confined to the region near 
the active electrode [26]. A study has shown that bipolar cells are more sensitive to long anodic-
first biphasic pulses due to the presence of cyclic nucleotide-gated (HCN) channels [183]. This 
can likely contribute to less axonal activation with anodic-first pulses due to indirect RGC 
activation, and provide an advantage for anodic-first pulses compared to cathodic-first pulses. If 
adding an IPG to small duration ratio AA stimulation maintains a focal response, then this pulse 
type can offer great potential for threshold reduction and focal phosphenes simultaneously. 
Experimentation with combinations of AA and IPG will be necessary to suppport this claim. We 
based our model on a previously published RGC model [153]. Although this model has a relatively 
simple geometry, it has predicted an experimental finding confirmed by our prior work, 
specifically that pulse widths below 0.1 ms avoid axonal activation [27]. However, a number of 
details have not been included in the model that might affect the threshold values. We investigated 
only a single electrode-retina distance, though it has been shown that this distance affects 
excitability [184]. Different RGC types and neurite geometries respond differently to electrical 
stimulation [185], [186], and using a disc electrode might affect RGC responses [182]. Thus, the 
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specific predictions of our modeling study (e.g. using a duration ratio less than 5) may not hold 
when other models are used, and when tested clinically. But more generally, the model predictions 
are consistent with our clinical data and the results taken together  support the claim that 
asymmetric pulses are an important feature to include in future prosthesis design, to allow 
optimization of pulse parameters. 
The effects of AA stimulation had a similar pattern among our human participants, but 
variability inherent in human subjects testing made these results less clear. Recruitment is a 
challenge. We were able to enroll four participants in these experiments. Argus II subjects are 
typically elderly, and due to their blindness, are dependent on others for transportation. Three of 
the four participants live several hours away from the University of Michigan, which further 
limited their participation. The number of electrodes tested was also small because experiments 
were repetitive and mentally taxing for the participants and their time on campus was limited. We 
used manual process to measure perception thresholds since the automated process could not 
deliver anodic-first pulses. This added to the testing duration. In addition to the small sample size, 
other factors contributed to variability in participants’ responses. Participants’ accuracy in 
reporting phosphenes can be influenced by the time they take to respond to stimulation and their 
background visual activity (spontaneous phosphenes). This background activity can vary day-to-
day. Intersubject differences that might be introducing variability to our data include the position 
of the implant on the retina, the electrode-retina distance, and the amount of retinal degeneration 
under the implant. The comparison of perception probabilities in response to different pulse types 
and IPGs was done at a single amplitude value due to the following reasons: 1) The software 
limitation prevented us from directly measuring the thresholds and 2) Our amplitude selection 
criteria and the tedious nature of the experiments did not allow for testing with more settings. The 
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pattern of change in perception probability can be a representation of change in perception 
threshold. However the variability of location of the chosen amplitude on the logistic curve (based 
on the three criteria mentioned in the methods section), introduces some noise to the perception 
probability values. 
Phosphene shape analysis revealed no significant difference among percept elongations 
with different pulse types. We expected less elongated phosphenes with short SA stimulation based 
on our in vitro findings. We have demonstrated that this pulse type activates cell bodies 
preferentially and avoids axonal stimulation, resulting in a more focal response [26]. In the current 
study, phosphene elongation was compared for different pulse types at only one amplitude. Since 
pulse amplitude has been shown to effect the elongation of activation area with SA stimulation 
[26], this comparison needs to be done at different amplitudes for a more valid comparison with 
the in vitro study, but was not possible with the limitations on AA pulse amplitude. We observed 
a significant increase in phosphene size with AA stimulation compared to SC and SA in participant 
2. Larger phosphenes with AA stimulation may be due to the lower activation thresholds with this 
pulse type, but this was noted in only one participant. Overall, there were not reliable trends 
relating pulse type to phosphene shape.  
Our results suggest that incorporating asymmetric stimulation as an option can improve 
retinal prosthesis function. Lower perceptual threshold provides a wider dynamic range for 
stimulation amplitudes and phosphene sizes, which results in more flexibility for retinal 
stimulation. In addition, it allows for individual usage of electrodes that were previously grouped 
with neighboring electrodes due to high thresholds, and potentially improving the perception 
resolution. Lower perceptual thresholds will also result in lower power consumption. Our 
conclusions are limited by the small sample size and must be validated in a larger number of 
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participants. On the whole, our data demonstrates the need for more flexible programming options 
in retinal prostheses. Optimization of the stimulation protocol for each patient will be necessary 
for the best outcomes. Systems that can only produce symmetric, biphasic pulses will limit 
optimization. 
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Chapter 3 : Closed-loop Optimization of Retinal Ganglion Cell Responses to Epiretinal 
Stimulation: A Computational Study 
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3.1. Abstract  
Retinal prostheses improve vision for patients with retinal degeneration. However, the 
shape recognition ability of retinal prostheses users is limited due to the low visual resolution of 
these devices. Off-target retinal ganglion cell (RGC) activation is an important contributing factor 
to the low stimulation precision. Previous research has shown RGC spatial activity and perception 
of shapes by users can be difficult to predict due to the complexity of retina structure and electrode-
retina interactions. In this study we demonstrate a method to iteratively search for optimal 
stimulation parameters that create focal RGC activation in silico. Our findings indicate that 
stimulation parameters can be customized to each electrode in a closed-loop manner. This 
approach can potentially eliminate the time-consuming process of searching a broad range of 




3.2. Introduction  
Retinal prostheses help restore functional vision to patients blinded by retinal degenerative 
diseases such as retinitis pigmentosa and age-related macular degeneration [21], [22], [70]. These 
devices produce percepts by electrically stimulating the remaining layers of the retina. Even 
though retinal prosthesis users report improvements in perceiving light and performing visual 
tasks, their ability to perceive shapes and letters remains limited [77], [80]. The best visual acuity 
is 20/1260 [99] for epiretinal and 20/460 [52] for subretinal implants. These values are lower than 
the acuity level for legal blindness (20/200). Perception quality is highly dependent on the 
capability to precisely activate the target retinal cells. However, in vitro studies have demonstrated 
off-target retinal ganglion cell (RGC) activation in response to electrical stimulation [26], [27]. 
Human subject testing has also shown that a single electrode activation results in perception of 
elongated phosphenes in subjects, confirming the in vitro results with respect to off-target 
activation of RGCs [73], [88]. Off-target stimulation results from a number of factors including 
unintended axonal activation, electric field spread [71], [187], large electrode size, and 
spatiotemporal interactions between electrodes [84]. A number of studies have focused on 
modulation of the stimulation protocol to avoid axonal activation. Using long duration pulses [27], 
and low-frequency sinusoidal stimulation [90] are amongst these stimulation strategies. Yet these 
protocols have not been proven clinically feasible due to high threshold charge densities. Our 
previous in vitro study showed that symmetric anodic-first stimulation, and asymmetric anodic-
first stimulation with small duration ratios (ratio of anodic to cathodic phase duration) can avoid 
axonal activation [26]. However the clinical results did not show significant improvement in 
phosphene shapes with these pulses [188]. In addition to phosphene elongation, phosphene shapes 
are highly variable across electrodes and subjects. This inconsistency confirms that despite the 
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clinical use of retinal prostheses, the visual experience of retinal implant users is inadequately 
understood [74]. Complex axonal pathways, variable electrode-retina separation, inconsistent 
health of the surviving neurons across the retina, and how the brain interprets neuronal responses 
contribute to this unpredictability [93], [94]. Thus, there is a crucial need to customize electrical 
stimulation parameters to each electrode for focal activation of the target neurons. 
In this study, we developed data-driven models of RGC spatial activity and optimized 
stimulation parameters with a closed-loop algorithm to elicit focal responses. This approach 
provides a method to quickly search through a broad range of pulse parameters to achieve the 
desired RGC activation.  
 
3.3. Methods 
3.3.1 Data-driven Modeling of RGC Spatial Activity 
Calcium images from previous in vitro experiments [26] were used to create data-driven 
models of RGC response to electrical stimulation for 48 regions (from 11 mouse retinas). Calcium 
imaging reveals RGC activity using the Ca2+ transient change in spiking neurons. GCaMP6f was 
expressed in RGCs by intravitreal injection of an adeno-associated virus (AAV) vector two-four 
weeks prior to sacrificing the animal. Spatial activity of RGCs in response to a single electrode 
stimulation was quantified with two descriptors: area and eccentricity. Area was defined as the 
area of the best-fit ellipse to the calcium activity, and eccentricity was defined as the ratio of the 
distance between the ellipse foci to its major axis length. Eccentricity values are always between 
0 and 1 (0 is a circle and 1 is a line segment), and are used as a measure of response elongation. 
Calcium images were recorded in response to a train of anodic-first pulses at 120 Hz frequency 
lasting 5 seconds. Cathodic phase duration was always 40 s and the anodic phase duration 
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changed based on the duration ratio. Electrical stimulation parameters included pulse amplitude 
and type. The range for pulse amplitude and type was 10 to 100 A and 1 to 20 respectively. Pulse 
type is defined as the ratio of the anodic to cathodic phase duration and pulse amplitude is the 
amplitude of the cathodic phase in A. For the purpose of this study we used calcium image 
responses to 50 different combinations of pulse amplitude and type.   
 
A single model could not be formulated to define the relationship between pulse parameters 
and spatial response descriptors that was consistent across the 48 retinal regions. Therefore, we 
trained feedforward artificial neural networks (ANN) for each region separately to quantify this 
relationship. Data points were divided into three subsets of training (80%), validation (10%) and 
test (10%). The inputs to the networks are pulse amplitude and type, and outputs are area and 
eccentricity. The ANNs include ten hidden layers and they all have hyperbolic tangent transfer 
Figure 3. 1. Neural network models for area vs. pulse amplitude and type in all 48 retinal regions. The z-axes show area in 
pixels. X-axes and y-axes show pulse amplitude and type.   
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functions. We used MATLAB built-in functions and the Levenberg-Marquardt backpropagation 
method for training the networks. Figure 3.1 and 3.2 show the fitted neural networks for area and 
eccentricity in all 48 retinal regions.  
 
3.3.2. Closed-loop Search for Optimal Stimulation Parameters 
The desired RGC activation has an area equal to the electrode area and eccentricity of zero 
(i.e. circular). A closed-loop optimization algorithm was developed to search for optimal 
stimulation parameters that elicit the desired RGC activity by minimizing the following objective 
function: 
 
                                                      𝑓(𝑎, 𝑡) = |𝐴(𝑎, 𝑡) − 𝐶| + 𝐸(𝑎, 𝑡)                       (1)                        
Figure 3. 2. Neural network models for eccentricity vs. pulse amplitude and type in all 48 retinal regions. The z-axes show eccentricity 
values. X-axes and y-axes show pulse amplitude and type.    
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where A and E are activation area and eccentricity respectively as functions of pulse 
amplitude (a) and type (t). C is a constant representing the electrode area. Area values were 
normalized to the maximum of the RGC activation area in each region.  
An interior point algorithm was used to find the minimum of the objective function in each 
region [189], [190], [167]. The algorithm combines line search and trust-region steps to decrease 
the objective function value. At each iteration the algorithm selects the next testing point based on 
the direction of change in the objective function value and stops searching when the minimum 
value of (1) is found. The FMINCON function from MATLAB optimization toolbox was used to 
implement this algorithm. Fig. 3.3 shows a summary of the parameter optimization process. 
 
Figure 3. 3. Flow chart of the optimization process. Area and eccentricity values are calculated in each 
iteration in response to a combination of pulse amplitude and type (a and t). The objective function (f) is 
calculated based on area and eccentricity. The algorithm then determines if the minimum objective 
function value is achieved, and either updates a and t or ends the search accordingly. Note that the 
calcium imaging block translates into an ANN in the optimization process. Calcium image demonstrates 
the best-fit ellipse (yellow) and the electrode location (blue).    
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3.4. Results 
3.4.1 Artificial Neural Network Training  
 Fig. 3.4. A-B show two examples of area and eccentricity maps as functions of pulse 
amplitude and type, and their resulting objective function. These examples demonstrate the 
different behavior of spatial RGC responses to the same range of stimulation parameters, and the 
need for developing an individual model for each region. Stimulation parameters that did not result 
in a calcium response were eliminated from the data points used for modeling. ANNs were created 
for activation area (A) and eccentricity (E), and the objective function was constructed based on 
(1). The performance of ANNs was quantified as the mean squared error (MSE) between the 
trained model and the experimental data points. The performances on all data points as well as on 
the test data set for all 48 regions are shown in Fig. 3.4 C.  
A) C)
B)
Figure 3. 4. ANN performance and examples. A,B) Two examples for area, eccentricity, and objective function maps as 
functions of pulse amplitude and type. The blue dots represent the experimental data points. Area values are normalized to the 
maximum area value in each region. Color bars do not have units since all values are normalized. C) ANN performance 
quantified as MSE across all data points (top), and test data points (bottom). Each box plot represents MSEs for 48 regions. Black 
diamonds show the mean value for each box plot and the red plus signs show the outliers. 
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3.4.2. Optimizing Stimulation Parameters for Focal RGC Activation  
Optimization was performed individually in each region. The initial condition was chosen 
as the point with minimum value of pulse amplitude and type. Examples of the closed-loop search 
are shown in Fig. 3.5. An average of 8±5 iterations were required to converge to the optimal 
parameters for focal RGC activity. This number is much lower than 50 which is the number of 
parameter combinations tried experimentally to find the optimal parameters for focal activation.  
The algorithm explores the continuous space fitted to the experimental data, therefore the 
optimal point found by the algorithm was not amongst the experimental data points in most cases. 
However, the calcium image resulting from the closest stimulation parameters to the optimal point 
was extracted and the corresponding images are shown for examples in Fig 3.5 These images show 
relatively focal RGC activities with only sparse axonal stimulation. This further confirms that the 
algorithm is effective in finding the optimal stimulus parameters for different regions with various 
A) B)
C) D)
Figure 3. 5. A-D) Four examples of automatic closed-loop search for optimal parameters. The red dot is the starting point, the 
yellow dots represent the search points in intermediary iterations, and the green dot is the end point. Calcium image for the 
experimental data point closest to the end point is shown in front of each objective function example. Blue circles represent the 
electrode location.    
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response characteristics. Fig. 3.6 shows the optimal solutions for focal RGC activity for the 48 
retinal regions.  
 
3.5. Discussion 
We have presented a method for automatic closed-loop searching of optimal stimulation 
parameters for the desired spatial response of RGCs. We have shown that an optimization 
algorithm can guide the parameter search effectively and find optimal parameters with a few 
iterations (8±5). This approach can reduce the exploration time significantly compared to a manual 
search, especially when the parameter space is large. We only used two pulse parameters to 
construct our objective function. Effectiveness of this algorithm should be tested for higher 
dimension parameter spaces (e.g. pulse width, frequency, inter-phase gap, etc.). In most regions 
Figure 3. 6. Optimal stimulation parameters across 48 retinal regions. 
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there were many parameter combinations that resulted in a low objective function and a near 
optimal solution. The final solution found by the algorithm is not necessarily the global minimum. 
Defining a range of acceptable area and eccentricity values will be helpful for future experiments. 
However, those values might vary across regions due to intrinsic differences between regions.  
 Our data indicated that RGC spatial activity can vary for different regions in response to 
the same stimulation parameters. This finding confirms the previous clinical studies with respect 
to phosphene shape inconsistency across different electrodes and subjects [74]. Future work 
includes performing in vitro calcium imaging of RGCs to verify this method. For real time 
optimization in vitro, this algorithm needs prior knowledge of the retinal response and local 
derivative information in order to select the next iterations effectively. Therefore, a few trials might 
be necessary to create a simple ANN or re-train the most similar model to our in vitro retina before 
proceeding with the optimization process. Models will be dynamically re-trained with each new 
recording to improve performance. This will increase the overall time for optimization, but will 
still allow fewer test conditions overall. Validation experiments will require a full parameter space 
search to ensure that an optimal result was reached when using a model based on a few trials. 
Algorithms that do not require prior knowledge of the system such as evolutionary algorithms and 
stochastic searching will also be considered for in vitro optimization. However, these methods 
generally require many iterations before converging to the optimal point. In this project, optimal 
stimulation parameters were identified using particle swarm optimization, and the average number 
of trials with this method was 53. In addition, the objective function had to be evaluated at every 
point in the parameter space at each iteration, adding to the total number of measurements needed 
in vitro and in clinic, which makes this method less efficient for optimization in these settings.   
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If applied clinically, the approach presented here could shorten the repetitive process of 
requiring users to draw phosphenes compared to a manual search for optimal parameters. The 
ANNs trained on in vitro data could be used as a starting point in human subject experiments, or 
new ANNs can be trained on a few drawings and dynamically re-trained over the course of 
optimization. Our prior work has shown that spatial activation patterns recorded during in vitro 
experiments and human perception of phosphene shape are influenced in a similar way by 
adjusting pulse parameters. Specifically, pulse durations greater than 20 ms created focal responses 
in vitro and smaller, rounder percepts in people [27]. Findings of this project could lead to the 
development of a clinically applicable system for electrode-specific optimization of stimulation 
protocol, improving the overall outcome of retinal prostheses.
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4.1. Abstract  
Retinal prostheses aim to improve visual perception in patients blinded by photoreceptor 
degeneration. However, shape and letter perception with these devices is currently limited due to 
low spatial resolution. Previous research has shown the retinal ganglion cell (RGC) spatial activity 
and phosphene shapes can vary due to the complexity of retina structure and electrode-retina 
interactions. Visual percepts elicited by single electrodes differ in size and shapes for different 
electrodes within the same subject, resulting in interference between phosphenes and an unclear 
image. Prior work has shown that better patient outcomes correlate with spatially separate 
phosphenes. In this study we use calcium imaging, in vitro retina, neural networks (NN), and an 
optimization algorithm to demonstrate a method to iteratively search for optimal stimulation 
parameters that create focal RGC activation. Our findings indicate that we can converge to 
stimulation parameters that result in focal RGC activation by sampling less than 1/3 of the 
parameter space. A similar process implemented clinically can reduce time required for optimizing 
implant operation and enable personalized fitting of retinal prostheses. 
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4.2. Introduction  
Retinal implants help improve functional vision for patients blinded by retinal degenerative 
diseases such as age-related macular degeneration and retinitis pigmentosa [21], [22], [70]. 
Percepts are created by electrically stimulating the remaining cells of the retina, including retinal 
ganglion cells (RGC) and bipolar cells. Patients with implants report improvements in perceiving 
light, detecting motion, and following lines on the ground while walking. However, their ability 
to recognize shapes and letters is currently limited [77], [80]. The best visual acuity is reported as 
20/1260 [99] for epiretinal and 20/460 [52] for subretinal implants, both of which are lower than 
the acuity level for legal blindness (20/200). 
The ability to precisely stimulate target neurons and avoid off-target activation is critical 
to create focal, non-overlapping percepts. However, human subject testing has shown that a single 
electrode often elicits elongated percepts [10], and in vitro studies have demonstrated off-target 
stimulation of retinal ganglion cells, confirming the clinical results [26], [27]. Unintended axonal 
activation is an important factor that contributes to elongated responses and low resolution of 
retinal stimulation. Other factors include large electrode size, electric field spread [71], [187], and 
spatiotemporal interactions between electrodes [84]. Prior work has related visual acuity and other 
visual task performance metrics with two point resolution in retinal prosthesis patients [191]. Thus, 
creating focal percepts is important for better patient outcomes with artificial vision systems.  
Previous studies have focused on modulation of stimulation parameters to avoid axonal 
activation. Some of these strategies include using long duration pulses [27], and low-frequency 
sinusoidal stimulations [90]. While successful at avoiding axonal activation, these protocols have 
not proven to be feasible clinically due to high threshold charge densities associated with long 
pulse durations. Our previous study showed that symmetric and asymmetric anodic-first pulses 
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with low duration ratios (ratio of anodic to cathodic phase duration) can preferentially activate 
RGC somas and reduce axonal activation. However subsequent clinical experiments did not show 
significant improvement in phosphene elongation with those pulses, which may be due to the 
limited parameter space explored in these tests [188]. In addtion to phosphene elongation, 
phosphene shapes and thresholds are highly inconsistent across electrodes and subjects [10]. This 
variability confirms that despite clinical use of retinal implants, the visual experience of patients 
is not adequately understood [74]. Contributing factors to these inconsistencies are variable 
electrode-retina separation, complex axonal pathways, heterogeneous degeneration, and 
perceptual interpretation of electrically elicited neural activity [93], [94]. Previous studies have 
shown that modifying stimulus parameters can transform the spatial RGC activity [26], and 
phosphene shapes [73]. Manually tuning each electrode is time consuming and tiring for patients, 
even when pulse shapes are limited to symmetric, biphasic pulses. Adding asymmetric pulses as 
an option will increase flexibility and may offer some benefits with respect to threshold and percept 
consistency, but this expands the parameter space to cover during a fitting procedure. Patient 
participation is required to confirm improvements in percept shape, but a prolonged fitting 
procedure will diminish the patient’s willingness and ability to provide useful feedback. Therefore, 
there is a crucial need to make the fitting process as efficient as possible.  
Optimization algorithms have been applied to aid clinical decision making for deep brain 
stimulation implants [192]. In this study, we demonstrate a process that optimizes RGC spatial 
activity. We developed neural network (NN) models of RGC spatial activity and a real-time 
optimization method to search for stimulation parameters that elicit focal responses from in vitro 
retina. Using this approach, we can rapidly identify stimulation parameters that produce a focal 
response based on sampling less than 1/3 of the possible pulse parameter combinations. A similar 
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process may be applicable to a clinical setting for efficiently tuning phosphene shape to improve 
the function of visual prostheses. 
4.3. Methods  
4.3.1. Overview  
Wild-type mice C57BL/6 (n = 10) aged 3-4 weeks purchased from Envigo were used for 
calcium imaging experiments. Mice were injected with an adeno-associated virus (AAV) vector 
encoding a genetically encoded calcium indicator (GECI) 3 – 4 weeks prior to being euthanized 
for experiments. All procedures were approved by the Institutional Animal Care and Use 
Committee (IACUC) and the Institutional Biosafety Committee (IBC) at the University of 
Michigan. 
4.3.2. Adeno-Associated Virus Vector (AAV) production  
pGP AAV-CAG-Flex-JCaMP7f-WPRE (Addgene #104496) was obtained from Addgene.  
To make pGP-AAV-CAG-JGCaMP7f-WPRE 1 g of the Addgene plasmid was incubated with 4 
units of Cre Recombinase (New England Biolabs cat# M0298) for 30 minutes at 37 C.  The Cre-
plasmid reaction was then cleaned up using the Monarch® PCR and DNA clean up kit from New 
England Biolabs and resuspended in 35 L of elution buffer. Two microliters of the cleaned-up 
Cre-plasmid reaction was then transformed into chemically competent NEB Stable bacteria using 
standard procedures and grown on LB Ampicillin plates.  Colonies were picked and mini-prepped.  
The obtained clonally isolated DNA was then sequenced at the University of Michigan Advanced 
Genomics Core to identify a clone that had Cre mediated flipping of the pGP AAV-CAG-Flex-
JCaMP7f-WPRE flex cassette.  The resulting vector was named pGP-AAV-CAG-JGCaMP7f-
WPRE.  This vector is based on the AAV2 inverted terminal repeats (ITR). AAV2 has been 
reported to be best for labeling RGCs, as it transduces the largest number of cells after intravitreal 
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injection [136], [193]. CAG promoter in combination with AAV2 has been able to target the 
majority of RGCs in mammalian retina [194].  
4.3.3. Intravitreal AAV injection  
To transduce the GECI jGCaMP7f in RGCs, pGP-AAV-CAG-Flex-jGCaMP7f-WPRE 
(Addgene #104496) was obtained from Addgene (Watertown, MA). The plasmid was then 
modified by the University of Michigan Vector Core to create the final vector pGP-AAV-CAG-
jGCaMP7f-WPRE. Mice were anesthetized with intraperitoneal injection of ketamine (100 mg kg-
1) and xylazine (10 mg kg-1). Pupils were dilated with 1% tropicamide and 2.5% phenylephrine 
hydrochloride. Topical tetracaine hydrochloride was applied for local anesthesia. A pilot hole was 
created through the sclera, choroid, and retina 1 – 2 mm posterior to the corneal limbus using a 30-
gauge needle. A 5 l Hamilton syringe (Hamilton Robotics, Reno, NV) with a 32-gauge blunt 
needle was used to inject 1 l (1.83 x 1012 vg/ml ) of pGP-AAV-CAG-jGCaMP7f-WPRE in the 
vitreous area (between the lens and retina). Injection was done slowly over 30 seconds and left in 
place for another 30 seconds after injection and slowly retracted to minimize leakage. Antibiotic 
eye ointment was used on the injection site to prevent infection.  
4.3.4. Calcium imaging 
Retinas were harvested 3 – 4 weeks [26] after injecting pGP-AAV-CAG-jGCaMP7f-
WPRE. Animals were anesthetized with ketamine (100 mg kg-1) and xylazine (10 mg kg-1). Both 
eyes were enucleated and hemisected inside a perfusion chamber filled with bicarbonate-buffered 
Ames’ Medium (Sigma-Aldrich, St. Louis, MO). After removal of both eyes animals were 
euthanized by CO2 overdose. Isolated retina was flattened by making four cuts on the periphery. 
Vitreous was removed with fine forceps to ensure tight coupling between retina and the 
microelectrode array (MEA). The MEA formed the bottom of the perfusion chamber. Retina was 
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then mounted on a porous membrane (cat. No. JVWP01300; Millipore) attached to a titanium ring 
and then placed on the transparent MEA with retinal ganglion cells facing the MEA. During the 
experiment, retina was superfused with bicarbonate-buffered Ames’ Medium equilibrated with 5% 
CO2 - 95% O2 gas, and adjusted to 280 mOsm. Solution was kept at 33 C and had a flow rate of 
4 – 5 ml min-1. Fluorescence excitation was induced by a super bright white light emitting diode 
(LED). Excitation and emission light were passed through a filter set (49002 - ET - 
EGFP(FITC/Cy2), Chroma Technology Corp, Bellows Falls, VT) and images are captured by an 
electron-multiplied charge-coupled device (EMCCD) camera (iXon 897, Andor Technology, 
Belfast, Northern Ireland) through an inverted Olympus UPLFLN 0.3 numerical aperture (NA) 
10 objective at 10 Hz.  
4.3.5. Electrical stimulation  
A transparent microelectrode array (MEA) constructed from glass, indium tin oxide, silicon 
nitride, and SU-8 epoxy photoresist was used for electrical stimulation [26]. The MEA contained 
60 disk electrodes with 200 m diameter and 500 m electrode pitch. Electrical stimulus pulses 
were generated by the PlexStim system (Plexon Inc., Dallas, Texas) controlled by a computer 
software. A custom circuit board was used to relay the electrical signal to the MEA. A platinum 
wire placed on top of the recording chamber was used as the return electrode. Stimuli consisted of 
charge balanced, biphasic, anodic-first current pulses delivered at 120 Hz for 5 seconds to evoke 
a calcium response. Five different pulse types were used in experiments: symmetric anodic-first, 
asymmetric anodic-first with duration ratio of 2, 5, 10, and 20. Duration ratio is defined as the ratio 
of the anodic phase to cathodic phase duration. Pulse amplitude range was 20 – 140 A (with 10 
A increments) for the cathodic phase, and the anodic phase amplitude was calculated according 
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to the duration ratio to keep the pulse charge balanced. Cathodic phase duration was 100 s in all 
experiments. A total of 46 pulse parameter combinations were used at each retinal region.  
 
4.3.6. RGC spatial activity analysis 
For each stimulation protocol, the fluorescence images around the active electrode were 
recorded at 10 fps. Images were captured for 5 seconds before and 5 seconds during electrical 
stimulation. The baseline image was obtained by averaging images 2 – 3 seconds after recording 
initiation, and the stimulation image was obtained by averaging images 2 – 3 seconds after 
stimulation initiation. RGC spatial activity was obtained by subtracting the baseline image from 
the stimulation image. The resulting calcium transient image (F) was further normalized with 
respect to baseline (F), and a threshold was selected (F/F > 15%) to remove noise based on the 
typical noise in the fluorescent signal. The shape of the RGC spatial activity (response shape) was 
quantified with two descriptors: activation area and eccentricity. Activation area was defined as 
the area of the best-fit ellipse to the RGC spatial activity, and eccentricity was defined as the ratio 
of the distance between the ellipse foci to its major axis length. Eccentricity values are always 
between 0 and 1 (0 is a circle and 1 is a line segment), and are a measure of response elongation. 
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4.3.7. Optimization pipeline overview 
We use artificial neural networks (NN), a convolutional neural network (CNN), and an 
optimization algorithm to iteratively search the parameter space and classify activation area and 
eccentricity, to converge to the desired response shape. Two NNs, based on images recorded 
during the experiment, are used to estimate surfaces for activation area and eccentricity and the 
resulting objective function. The optimization routine uses the objective function surface to predict 
optimal stimulus parameters. We record the RGC spatial activity to the predicted optimal stimulus 
parameters and classify the resulting image using the CNN. The procedure ends if the required 
class is achieved, and continues otherwise. Fig. 4.1 illustrates a flow chart of the optimization 
steps. 
 
Figure 4. 1. Flow chart of the optimization process. A group of 5 different stimulus trains are delivered at the beginning. Calcium 
images of spatial RGC activity are recorded and analyzed for area and eccentricity values. Neural networks are trained for area and 
eccentricity as functions of pulse amplitude and type. Interior point algorithm is run to find optimal stimulation parameters for a 
focal response, which is then delivered to the retina and the resulting RGC spatial activity is recorded and classified by the CNN. 
If the image is classified as the required class, optimal amplitude and type are reported as outputs. Otherwise, the loop continues 
with 10, 15, 20, and 46 different stimulus trains. Blue circles show the electrode position on calcium images, and the best fit ellipse 
is outlined in red. 
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4.3.8. Neural network training 
Based on our previous results on empirical modeling of RGC spatial activity [195],a single 
model could not be created for the relationship between stimulus parameters (pulse amplitude and 
type) and the spatial response descriptors (activation area and eccentricity) that was generalizable 
to all regions (a region is a retinal area above and nearby an electrode). Therefore, we chose to 
train feedforward artificial neural networks (NN) for each region separately to quantify this 
relationship. Data points were divided into three subsets for training (60-80%), validation (10-
20%) and test (10-20%), where the exact percentage was determined by the number of data points. 
The network inputs are pulse amplitude and type, and outputs are activation area and eccentricity. 
The NNs include a hidden layer of size 10 with hyperbolic tangent transfer functions. We used 
MATLAB (MathWorks, Natick, MA) built-in functions and the Levenberg-Marquardt 
backpropagation method for training the networks. 
 
4.3.9. Closed-loop search for optimal stimulation parameters 
A closed-loop optimization algorithm was developed to find stimulation parameters that 
elicit the desired response shape by minimizing the following objective function: 
 
                                                     𝑓(𝑎, 𝑡) = |𝐴(𝑎, 𝑡) − 𝐶| + 𝐸(𝑎, 𝑡)                                               (1)                              
 
where A and E are activation area and eccentricity respectively as functions of pulse 
amplitude (a) and type (t), as estimated by the NNs. C is a constant representing the electrode area. 
Area values were normalized to the maximum value of the activation area for a given region. The 
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ideal response shape has an activation area equal to the electrode area and eccentricity of zero (i.e. 
circular). 
An interior point algorithm was implemented in order to find the minimum of the objective 
function in each region [189], [190], [167]. The algorithm combines line search and trust-region 
steps to reduce the objective function value. At each iteration the next testing point is selected 
based on the direction of change in the objective function value and searching stops when the last 
step is smaller than the step tolerance (10-4). The FMINCON function from MATLAB 
optimization toolbox was used to implement this algorithm.  
In each retinal region we started by recording the fluorescent transient images in response 
to 5 different sets of stimulation parameters. These points were chosen by randomly selecting one 
amplitude (20 – 140 A) for each pulse type. NNs for activation area and eccentricity were then 
trained on the images of RGC spatial activity and the objective function was created based on (1). 
The interior point algorithm was used to search for the minimum of the objective function and the 
optimal stimulation parameters. The next step was delivering a stimulus train with the predicted 
optimal parameters and recording the spatial RGC activity. In most cases the optimal parameters 
were modified to settings possible for delivery with the electrical stimulator. Similar steps were 
done on 10, 15, 20, (by randomly selecting 2, 3, 4 amplitudes per class) and 46 sets of stimulation 
parameters. 
 
4.3.10. Convolutional neural network training for calcium image classification 
Prior work using a database of previously recorded RGC spatial activity images [26] 
showed that in most regions there were many pulse parameters combinations that resulted in a near 
optimal solution, and the solution found by the algorithm was not necessarily the global minimum 
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of the objective function. Therefore, we created 5 different classes for response shape and used 
that as a measure of the desirability of the response shape elicited by the predicted optimal stimulus 
parameters. Initially, we categorized our images into 5 classes based on activation area and 
eccentricity values (Table 1). One metric that distinguishes different classes from each other is 
having an area larger or smaller than twice the electrode area. This metric was chosen because it 
determines whether the RGC activity overlaps with adjacent electrodes according to the electrode 
pitch in the MEA, which is similar to the pitch in Argus II implants. Another classification metric 
is having an eccentricity larger or smaller than 0.5. This number was chosen as the mid-point in 
the eccentricity range. Fig. 4.2 shows examples for each class of images. An initial total of 5466 
images were labeled manually to more accurately distribute images into 5 classes: class 0 = no 
meaningful activity, class 1: round and focal response, class 2: elongated and focal response, class 
3: round and large response, class 4: elongated and large response. Subsequent data augmentation 
to balance the number of images per class increased the total number to 8622. Data augmentation 
was implemented through orthogonal rotations, image flipping, and addition of gaussian and salt 
and pepper noise to classes 1, 2, and 3.  
Convolutional neural network (CNN) architecture consisted of two convolutional layers 
each containing 32, 33 kernels and a subsequent rectified linear unit (ReLU) activation functions. 
Towards the end the network has 2 fully connected layers with 32 and 5 nodes respectively. The 
training protocol involved the use of ‘Adam’ [196] optimizer with categorical cross-entropy loss 
and learning rate of 0.001. A 20% dropout, L2-norm regularization (λ = 0.0007), and a batch size 
of 32 were used. Training-test data split was 90-10%, and a further 90-10% training-validation 
split was done on the training data. Training was done over 25 epochs while monitoring accuracy 
and loss performance metrics.  
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Table 4.1. Image Classification Information 
 
 
4.4. Results  
4.4.1. In silico prediction of optimal stimulus parameters with NNs based on RGC spatial 
activity data 
RGC spatial activity was obtained from 24 retinal regions during the experiments. Fig. 4.3 
A – C shows three examples of objective function maps based on pulse amplitude and type. These 
examples demonstrate the variability of RGC spatial activity to the same range of stimulation 
parameters. Stimuli that did not result in a calcium response were not included in the data points 
used for modeling. NNs were created for activation area (A) and eccentricity (E), and the objective 
function was constructed based on (1). The performance of NNs was quantified as the mean 
squared error (MSE) between the trained model and the experimental data points. The 
Class  Area  Eccentricity Initial number  Final number 
0 No meaningful activity 2045 2045 
1 < 2 electrode area < 0.5  257 1559 
2 < 2 electrode area > 0.5 754 1438 
3 > 2 electrode area < 0.5 30 1200 
4 > 2 electrode area > 0.5 2380 2380 
Figure 4. 2. Example images for each class. Class 0: no meaningful activity, class 1: round and small response, class 2: long and 
small response, class 3: round and large response, class 4: long and large response. 
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performances on the test data sets for all 24 retinal regions are shown in Table 2. The training time 
for NN and execution time for the interior point algorithm varied based on the amount of data and 
the number of iterations, respectively. But in general, these took less than 1 minute running on a 
standard desktop computer, without any attempt to optimize code. 
Examples of interior point optimization are shown in Fig. 4.3. The initial condition was 
chosen as the point with minimum value of pulse amplitude and type. The interior point algorithm 
explores the continuous space fitted to the experimental data in each region, therefore the optimal 
point found by the algorithm was not amongst the experimental data points in most cases. Due to 
limitations in the resolution of the electrical stimulator, the optimal amplitudes and types were 
rounded to parameters within the stimulator capability. Example RGC spatial activity resulting 
from the closest stimulation parameters to the optimal point are shown in Fig. 4.3 for each 
corresponding objective function map. These images show relatively focal RGC activities with 
only sparse axonal stimulation. This confirms that the NNs and interior point algorithm are 
effective at finding the optimal stimulus parameters for different regions with various response 
characteristics.  
Table 4.2.  Neural Network Performance (MSE) 
 
  
 5 points 10 points 15 points 20 points 46 points 
Area 0.0655±0.1068 0.0690±0.1049 0.0513±0.0858 0.0442±0.0600 0.0361±0.0394 
Eccentricity  0.0171±0.0228 0.0191±0.0408 0.0148±0.0332 0.0130±0.0182 0.0140±0.0205 
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4.4.2. Real-time search for optimal stimulation parameters in vitro 
Closed-loop optimization was performed in each region on objective function maps fitted 
to RGC spatial activity evoked by 5, 10, 15, 20 and 46 stimulus parameter combinations. As 
described in Fig. 4.1 and the previous section, the interior point algorithm predicted optimal 
stimulus parameters. Pulse parameters near the optimal settings were delivered to the retina and 
the RGC spatial activity was recorded. The CNN was used to classify the response shape evoked 
by both the randomly chosen stimulus parameters (used for NN training) and the predicted optimal 
stimulus parameters. The CNN performance was measured based on accuracy of predictions. Fig. 
Figure 4. 3. A-C) Three examples of closed-loop search for optimal stimulation parameters. Objective function maps are plotted 
against pulse amplitude and type. The interior point algorithm is used to search for the optimal stimulus. Red dots represent the 
initial condition (lowest amplitude and class), yellow dots are the intermediary points, and green dots are the optimal points. 
Calcium images resulting from the optimal stimulation parameters are below each objective function map. All 46 calcium images 
were used to create these objective functions. 
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4.4 is a confusion matrix for true labels vs. prediction labels, showing the prediction accuracies 
ranging from 93 – 100%. 
The CNN classification step determined if the search was completed or if the process 
should continue. Since our overall goal was to create a focal response area, class 1 is the most 
desirable class due to focal activation area and round shape. If the CNN classified the response 
shape as class 1, then the process was completed. Otherwise, a new set of data was collected with 
more data points. Class 2, 3, and 4 follow class 1 in terms of desirability. Class 0 means no 
meaningful activity in response to retinal stimulation. The best class in each retinal region was 
defined as the most desirable class achievable considering response areas across all stimuli. Class 
1 was not always achievable, but all regions yielded either a class 1 or 2 response area using this 
range of parameters.  Class 1 was reached in 7 out of 24 regions and Class 2 was reached in 17 out 
Figure 4. 4. Normalized confusion matrix for CNN accuracy. Individual class recognition rates are shown for test 
data. Accuracy values for correctly predicting each class are shown on the diagonal. 
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of 24 regions. Fig. 4.5 includes examples of the optimization process in two different retinal 
regions. The best possible class in these regions is 1 and 2 shown in Fig. 4.5A and Fig. 4.5B 
respectively. Best class was achieved after 10 and 15 trials in these examples. Fig 4.6. shows the 
possibility of getting best class vs. the number of trials. In all retinal regions, we achieved response 
Figure 4. 5. Examples for objective function maps at different iterations and the resulting optimal solution and calcium image. 
Colored dots are the classified calcium images for every stimulus train delivered at each iteration. Red boxes designate the optimal 
solution found by the algorithm. Calcium image corresponding to the optimal solution is shown below each objective function 
map. A) At the first iteration (5 points), the algorithm is converging to a solution with class 0 spatial activity. At iterations 2-5 the 
algorithm is converging to a solution with class 1 spatial activity. B) At the first and second iterations, the algorithm is converging 
to solutions with class 4 spatial activity. At iterations 3-5 the algorithm is converging to a class 2 spatial activity, which is the best 




shape with the best class after 20 trials. The average and median number of trials for achieving 
best class was 10. 
Figure 4.5 shows how the objective functions become more complex when more data is 
used to train the NN. Objective functions based on five points are simple, with gradients in one 
direction. As more data points are used to train the NN, the objective function surface becomes 
more complex. Figure 4.7 shows a boxplot of the number of trials needed to converge to best class 
across 24 retinal regions. Figure 4.8 shows the optimal stimulation parameters in all 24 regions, 
rounded to the closest value possible for delivery with the stimulator.  
 
Figure 4. 6. Probability of converging to the best possible class. Maximum number of trials to get the best class is 20 across 
all retinal regions. 
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Figure 4. 8. Box plot of the number of trials needed to converge to best class across 24 retinal regions. 
The black diamond shows the average number of trials.    
Figure 4. 7. Optimal stimulation parameters across 24 retinal regions. Size of the blue dots corresponds 
to the number of regions with the same optimal inputs. The optimized input values are graduated due to 




4.5. Discussion  
We have presented a process for guided modification of epiretinal stimulation parameters 
to produce a focal RGC response area.  Prior work in patients with Argus II retinal implants has 
shown the importance of increasing the focality of percepts. There has been a strong correlation 
between two point resolution and the grating visual acuity task; the higher the two point resolution, 
the better the visual acuity [191]. Further work established a link between visual acuity and 
performance on visually guided tasks, including line following, door finding, and letter 
recognition. Therefore, artificial vision can be improved by creating focal percepts from individual 
electrodes. 
We have shown that we can iteratively search and classify response areas using two NNs, 
a CNN, and an optimization algorithm. With this approach we were able to converge to the best 
possible response shape in all 24 retinal regions within 20 trials. The average number of trials 
needed to converge to a class 1 or 2 response shape was 10. To validate our approach, we 
performed a full parameter space search to identify the most desirable class possible when 
considering the entire parameter space. This process can reduce the exploration time significantly 
compared to a manual search, especially when the parameter space is large. For our experiments, 
we limited the free parameters to only two: amplitude and type. We used anodic-first pulses in this 
study based on our results from a previous study demonstrating anodic-first pulses elicit more focal 
activity and avoid axonal stimulation compared to cathodic-first stimuli [26]. Other fixed 
parameters included cathodic pulse width (100 s) and interphase gap (5s). Increasing the number 
of free parameters makes a manual process less likely to succeed. However, a large parameter 
 79 
space will also increase the time for a semi-automated optimization process like we demonstrate. 
In our process, we randomly selected pulse amplitudes for each of the five pulse types tested. If 
the desired class was not achieved, we randomly selected a new set of pulse parameters with five 
additional settings. A more efficient process may be able to use the prior set of data to inform the 
selection of the next set of parameters. 
In most cases there were many parameter combinations that resulted in a near optimal 
solution. Therefore, we defined five distinct response shape classes to discretize the desirability of 
the solution. This approach provides the flexibility to choose any of the 5 classes as the desired 
outcome by modifying multiplying factors for area and eccentricity, and the C constant in the 
objective function. We did not optimize for pulse efficiency, only for shape. Other studies have 
focused on optimizing pulse parameters for stimulation efficacy and lower thresholds by 
modifying pulse duration and polarities, however these studies haven’t optimized for spatial RGC 
activity [26], [197], [198]. Optimizing for efficiency can be added to our framework simply by 
selecting the most efficient of the several pulse types that create the most focal percept class. The 
optimal stimulation parameters predicted by the interior point algorithm were rounded to the 
nearest available parameter settings. The rounded settings sometimes were less optimal (as 
measured by the objective function value) than the original solution.  
The choice of training a CNN was based on the need for a rapid execution time and to 
eliminate any error in the ellipse fitting process. CNNs have recently received significant attention 
due to their superior performance in computer vision tasks such as image segmentation and 
classification [199], [200]. These deep learning models are comprised of learnable convolution 
filters that significantly reduce input image dimensions while preserving characteristic features 
necessary for good decision making by the subsequently cascaded multi-layer neural network. 
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The interior-point algorithm needs prior knowledge of the retinal response and local 
derivative information in order to select the next iterations effectively. Therefore, fitting NNs to a 
set of images at each iteration was necessary. Algorithms that do not require prior knowledge of 
the system such as evolutionary algorithms and stochastic searching can also be considered for 
optimization. However, these methods require evaluating the objective function at every point in 
the parameter space at each iteration and generally require many iterations before converging to 
the optimal point [201], [202].  
Our data indicated that RGC spatial activity can vary for different retinal regions in 
response to the same stimulation parameters. This finding in in vitro mouse retina confirms the 
previous clinical studies with respect to phosphene shape inconsistency across different electrodes 
and subjects [74]. Future work includes performing human subject testing to verify this method. 
If applied clinically, the approach presented here could shorten the repetitive process of requiring 
users to draw phosphenes compared to a manual search for optimal parameters. In place of calcium 
images, patient drawings [74] would be used to determine the focality of percepts. The NNs trained 
on in vitro data could be used as a starting point in human subject experiments, or new NNs can 
be trained on a few drawings and dynamically re-trained over the course of optimization. Our prior 
work has shown that spatial activation patterns recorded during in vitro experiments and human 
perception of phosphene shape are influenced in a similar way by adjusting pulse parameters. 
Specifically, pulse durations greater than 20 ms created focal responses in vitro and smaller, 
rounder percepts in people [27]. Findings of this project could lead to the development of a 
clinically applicable system for electrode-specific optimization of stimulation protocol, improving 
the overall outcome of retinal prostheses.
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Chapter 5: Investigating temporal properties of retinal ganglion cell responses to 
asymmetric anodic-first pulses 
 
A version of this chapter has been presented at the International Conference of the IEEE 
Engineering in Medicine and Biology Society (EMBC’ 18) 
 
5.1. Introduction  
Retinal prosthetic implants have helped improve vision in blind patients with retinitis 
pigmentosa (RP) and age-related macular degeneration (AMD), two of the common retinal 
diseases that lead to loss of photoreceptor cells and eventual blindness [21][97][50]. Patients with 
retinal prostheses have reported improvement in their light perception and performing visual tasks; 
however, their ability to perceive shapes and letters is currently limited due to the low precision of 
retinal activation [77][80]. Patients with implants who can recognize letters take an average of 
more than 40 seconds to do so [77]. A clinical trial showed that among 30 patients with retinal 
prostheses, about half of the electrodes had activation thresholds above the acute stimulation safety 
limit [99]. Even with a direct contact between the macula and electrodes, an average of 10% of 
electrodes had thresholds above the acute stimulation safety limit [97][88]. Electrodes that have 
high activation thresholds cannot be used individually and are grouped with adjacent electrodes, 
effectively creating a larger electrode area and lowering the stimulation resolution. Therefore, it is 
critical to investigate stimulation parameters that lower activation thresholds as it could provide a 
wider range of stimulus intensities for safe retinal activation in clinic [100], decrease charge and 
power consumption [100][101], and improve the resolution.  
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In Chapter 2, we investigated the effect of asymmetric waveforms on perception thresholds 
by human subject testing and computational modeling. In our previous work, we studied RGC 
thresholds in response to asymmetric waveforms using calcium imaging [26]. While calcium 
imaging allows for recording of RGC activity from a large number of cells, it does not provide a 
high temporal resolution. Intracellular recording through patch clamping provides unmatched 
temporal resolution and offers more details on cellular level responses such as spike latencies. We 
used single cell electrophysiology to study RGC responses to different stimulation parameters, 
mainly asymmetric anodic-first pulses. We demonstrate that asymmetric waveforms decrease cell 
activation thresholds compared to symmetric stimuli.  
 
5.2. Methods  
5.2.1. Retina Preparation 
 Wild type mice (C57BL/6) were anesthetized by intraperitoneal injection of ketamine (100 
mg/mL) and xylazine (20 mg/mL). Eyes were enucleated and hemisected using iris and spring 
scissors (F.S.T, Foster City, CA); after removing the lens, vitreous humor was removed from the 
surface of the retina using fine forceps (F.S.T, Foster City, CA), and retina was cut into four equal 
pieces. Dissection process was done inside the superfusion solution to maintain retina health and 
cell viability. Mice were then euthanized by CO2 overdose, and bilateral pneumothorax as the 
secondary mean. The dissected retina piece was placed on a piece of lens paper, which was then 
held in place with a slice anchor (harp) in the recording chamber. The superfusion solution was 
composed of Ame’s medium with sodium bicarbonate and glucose, bubbled with a 5%CO2 / 
95%O2 gas mixture, and adjusted to 280 mOsm osmolality. The retina was continuously 
superfused with the solution at 33 C throughout the experiments.  
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5.2.2. Electrical Stimulation and Recording  
To ensure maximum current is directed through the retina and to limit the current shunting 
around it, a 1.5 mm hole is created at the center of the recording chamber and the ground electrode 
is placed under the hole in a smaller chamber. A ring of vacuum grease is applied around the hole 
to serve as an extra insulation, and the lens paper with the retina piece is placed on top of it [203]. 
Retina is placed ganglion cell side up with the external stimulating electrode placed 50 m above 
it, and the ground electrode on the photoreceptor side (Fig. 5.1). STG-4008 stimulator and software 
from Multi-Channel Systems (Reutlingen, Germany) are used to deliver current pulses. Whole-
cell patch clamp recordings are done using patch electrodes with tip resistances ranging 5-8 M 
filled with internal solution containing (in mM): 111 K-gluconate, 5 NaCl, 4 KCl, 10 HEPES, 2 
EGTA, 4 Mg-ATP, 0.3 Na-GTP, 7 Tris-phosphocreatine, 0.1% Lucifer Yellow, and KOH to 7.3 
Figure 5. 1. Schematic of the stimulation and recording setup. (drawing is 
not to scale) 
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pH. Recordings are acquired and amplified using the Axopatch 200B amplifier and Clampex 
software. 
5.2.3. RGC Threshold Measurement 
Current pulses were delivered through the disk-shaped Platinum-Iridium electrode with 
125 m diameter, placed within 50 m laterally from the targeted RGC. Three types of current 
pulses were used in experiments: symmetric cathodic-first, symmetric anodic-first, and 
asymmetric anodic-first with 5, 10, and 20 phase duration ratios. Pulse durations were 80 s, 120 
s, and 500 s. The two shorter pulses mainly lead to direct activation of RGCs and result in lower 
threshold charge densities, which provide flexibility in modifying the pulse amplitude [100][101]. 
Pulses were delivered at 10 Hz frequency to avoid desensitization of retinal neurons to repetitive 
stimuli [111][87]. Baseline activity of ganglion cells were recorded before delivering stimulation 
of each type (cathodic-first, anodic-first, asymmetric anodic-first) to ensure consistency. The 
baseline spontaneous spike rate was calculated as the probability of a spontaneous spike occurring 
Figure 5. 2. (a)Stimulation/recording setup, (b)close-up image of whole-cell patch clamp recording with stimulation electrode 
on the right (dark shadow) 
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within 5 ms of the onset of the cathodic phase. The order of delivery of different current amplitudes 
was randomized to eliminate any threshold dependency on the direction of amplitude change. The 
activation threshold was defined as the amplitude at which an action potential is evoked in response 
to 50% of the total of 200 delivered pulses; if the spontaneous rate is not zero, the activation 
threshold is the midline between the spontaneous spike rate and 100% probability of evoking a 
spike. Only the spikes with their peaks occurring within 5 ms of the cathodic phase onset were 
counted as an evoked action potential since we were interested in direct activation of ganglion 
cells [55]. Dose-response curves were created for each pulse type for each cell by plotting the spike 




Where p is the spike probability, x is the current amplitude, and a, b and c are constants.  
 
5.3. Results  
Our results show an increase in spike probability when the stimulation amplitude is 
increased. Representative data for evoked spikes in an RGC within 5 ms of the cathodic phase 
onset of 200 anodic-first pulses is shown in Fig. 5.3.  
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RGC activation thresholds were calculated from fitted graphs to spike probabilities for each 
pulse type and duration (Fig. 5.4a). Figure 5.4b shows a RGC baseline activity and response to 
different stimulation amplitudes for the 0.5 ms pulse duration. The liquid junction potential was 
calculated based on the ion concentrations, valences, and mobilities and was subtracted from the 
recorded membrane voltage. Stimulus artifacts are visible in the recordings for the 200 delivered 
pulses. Our data on 7 ganglion cells show a decrease in thresholds with the 10-time asymmetric 
anodic-first pulse compared to the symmetric cathodic-first and symmetric anodic-first stimulation 








a d c b 
Figure 5. 3. Evoked action potentials in the 5 ms window after initiation of the cathodic phase of stimulus.(a)baseline activity 
(0.5 % spike probability). (b)20 uA- 0.5 ms anodic-first (1 % spike probability). (c) 40 uA- 0.5 ms anodic-first (41 % spike 
probability). (d) 100 uA- 0.5 ms anodic-first (100 % spike probability). 
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Figure 5. 5. (a) Dose response curves for 0.5 ms and 120 s pulse durations, (b) Evoked action potentials in a RGC in response to 
different stimulation amplitudes. 
Figure 5. 4. Threshold ratios for different pulse durations. Right: box plots for threshold ratio of 10-time anodic-first to cathodic-
first stimuli. Left: box plots for threshold ratio of 10-time anodic-first to anodic-first stimuli. 
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5.4. Discussion   
In this study we determined that asymmetric anodic-first stimulation is effective in 
reducing activation thresholds in RGCs. We did not record from enough cells to perform a robust 
statistical analysis, but given that these findings are consistent with Chapter 2, we expect that data 
from more cells would confirm these results. For future experiments, cells should be categorized 
based on their dendritic morphology and light response into three groups of ON, OFF, and ON-
OFF RGCs. Cell activation thresholds in these groups should be compared and the significance of 
threshold differences for the three pulse types should be studied separately in each group. 
The asymmetric anodic-first stimulation may be decreasing cell thresholds based on anode-
break excitation [26]. The amplitude range in which this pulse type can produce focal activation 
will determine its future practicality in clinic. We do not expect to see a significant difference 
between ON, OFF, and ON-OFF ganglion cell thresholds. It has been shown that with lower 
stimulation frequencies (5-10 Hz), the difference between ON and OFF ganglion cell activation 
thresholds is not significant [112]. However a significant difference between ON and OFF 
ganglion cell activation thresholds has been recorded in a study using high frequency (kHz) 
stimulation [167]. 
Studies have shown that adding interphase gaps equal to or greater than 0.5 ms reduces 
RGC thresholds by 20-25% [172] with cathodic-first biphasic pulses, as it delays the 
hyperpolarizing effect of the anodic phase. Adding an interphase delay to asymmetric anodic-first 
pulses, can reduce RGC thresholds possibly with a different mechanism. After applying a long 
hyperpolarization, the values of Hodgkin-Huxley parameters n and m are reduced while h is 
elevated. When the hyperpolarization is released, m quickly regains its normal value due to its very 
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short time constant (< 1 ms). But n and h take 3-10 ms to do so [176]. By having an interphase 
delay of less than 1ms, enough time is provided for the m value to go back to normal and make the 
net sodium current more than the potassium current, which can initiate an excitation. The 
relationship of the cell thresholds with the interphase delay duration is studied in silico in chapter 
2. An electrophysiology experiment to investigate this phenomenon would involve delivering 
asymmetric anodic-first and cathodic-first stimulation and comparing RGC activation thresholds, 
as it is described in chapter 2. Different interphase gaps should be applied to the anodic-first stimuli 
to determine the optimal gap for lowering thresholds. For a more accurate understanding, single-
channel patch clamp recordings could be performed to reveal the sodium and potassium channel 
dynamics over the course of stimulation. 
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Chapter 6: Discussion 
6.1. Summary of Main Contributions  
The main contributions of my dissertation are: 
1. I demonstrated a reduction in perception thresholds in Argus II retinal prosthesis users, 
using asymmetric anodic-first pulses, and symmetric cathodic-first pulses with an 
interphase gap. (Chapter 2) 
2. Biophysical modeling of an RGC confirmed the results from human subject testing. I 
extended the clinical results by testing a wide range of interphase gaps and duration 
ratios. I showed that pulses with small duration ratios ( 5) and long IPGs ( 2 ms), were 
predicted to be most effective for threshold reduction with short pulse widths (≤ 0.12 ms). 
Symmetric cathodic-first stimuli with IPGs longer than 0.5 ms, and asymmetric anodic-
first pulses with large duration ratios (≥ 20) were predicted to be most effective for 
threshold reduction with 0.5 ms pulse widths. (Chapter 2) 
3. I demonstrated a method for automatic closed-loop optimization of stimulation 
parameters to create focal RGC activity using an interior-point algorithm and neural 
network models. (Chapter 3) 
4. I extended the optimization approach and demonstrated real-time optimization of 
stimulation in vitro for focal RGC activity. I was able to converge to the most focal 
response with an average of 10 trials. (Chapter 4) 
5. I demonstrated a reduction in RGC activation thresholds with asymmetric anodic-first 
pulses in vitro using whole-cell patch clamp recordings. (Chapter 5) 
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6.2. Conclusion  
Retinal prostheses have helped improve vision in patients blinded by retinal degenerative 
diseases such as RP and AMD. While patients with implants report improvements in light 
perception and performing visually guided tasks, their ability to perceive shapes and letters 
remains limited [77], [80]. The best reported visual acuity for epiretinal and subretinal prostheses 
is 20/1260 and 20/460 respectively [52], [99]. Unintended activation of axon fibers, and using 
electrodes in unison due to high individual thresholds are important contributing factors to low 
image resolution. The ability to precisely activate target neurons and avoid off-target activation is 
crucial to creating non-overlapping percepts and improving the prosthetic image quality [191]. In 
addition, reducing perception thresholds helps improve device efficiency and allows individual 
usage of electrodes, which is a necessary step for improving resolution. In this thesis I investigated 
a novel pulse paradigm for threshold reduction by performing a clinical study of retinal implant 
users, and computational modeling of a RGC, and in vitro retina studies. I also demonstrated a 
method for iterative searching for optimal stimulation parameters that create the most focal RGC 
activity in silico. Using this method, I created a framework for closed-loop optimization of 
stimulation parameters for focal RGC activity in vitro.  
In Chapter 2, I investigated the effect of asymmetric waveforms and interphase gaps (IPG) 
on perception thresholds and shapes with epiretinal stimulation. Threshold measurements in Argus 
II implant users showed significant increase in perception probabilities in two out of three patients 
using AA and SCI stimuli compared to a standard symmetric cathodic-first pulse. Adding an IPG 
to the standard cathodic-first pulse increased perception probabilities significantly regardless of 
duration in one participant. Perception probabilities increased with the duration of IPG in the other 
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two participants, however not significantly. Adding an IPG to the AA pulse increased perception 
probabilities in one patient. Phosphene shape analysis revealed no significant difference between 
percept shape elongation with SC, SA, and AA stimuli. Average phosphene area was larger with 
AA stimulation compared to SC and SA. This difference was significant only for one participant. 
Our computational modeling study predicted lower activation thresholds with longer IPGs and 
higher duration ratio AA pulses. Combining AA stimulation with IPG showed that pulses with 
small duration ratios ( 5) and long IPGs ( 2 ms), were most effective in threshold reduction with 
short pulse widths (≤ 0.12 ms). Symmetric cathodic-first stimuli with IPGs longer than 0.5 ms, and 
asymmetric anodic-first pulses with large duration ratios (≥ 20) were predicted to be most effective 
for threshold reduction with 0.5 ms pulse widths. Our results suggest that incorporating 
asymmetric waveforms for retinal stimulation can improve the overall outcomes. Lower perceptual 
thresholds will improve device efficiency and battery life. In addition, it provides a wider dynamic 
range for stimulation amplitudes, and phosphene sizes and shapes. Lower thresholds will allow for 
individual usage of electrodes previously grouped with neighboring electrodes, and this potentially 
improves the overall image resolution. We expected less elongated phosphenes with short SA 
pulses based on our previous in vitro results [26]. We compared phosphene elongation only at one 
amplitude due to limitation in time. Since pulse amplitude can affect the elongation of spatial RGC 
activity, this comparison needs to be done at different amplitudes for a more thorough conclusion. 
Overall, our data demonstrates a need for flexible programming options in retinal implants. This 
will allow more flexibility for patient specific optimization of stimulation parameters [73], [204].  
In Chapter 3, I demonstrated a method for automatic closed-loop optimization of 
stimulation parameters for focal RGC activity. This approach included training neural networks to 
quantify the relationship between stimulation parameters (pulse amplitude and type), and response 
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area descriptors (area and eccentricity), and using an interior point algorithm to minimize the 
objective function. We showed that the optimization algorithm can effectively find optimal 
parameters with few iterations (8±5). Calcium images corresponding to the parameters closest to 
the optimal parameters showed round and focal RGC activity with only sparse axonal stimulation. 
We used a gradient based algorithm that needs prior knowledge of the response and local derivative 
information to select the next iterations. Therefore, if this approach is used in real-time, fitting a 
continuous surface to a set of images at each iteration is necessary. Algorithms that do not require 
knowledge of the system such as stochastic searching and evolutionary algorithms require 
evaluating the objective function at every point in the population, and generally require many 
iterations before converging to an optimal solution [201], [202]. This study also indicated that 
spatial RGC activity, and the optimal parameters can vary greatly between different retinal regions, 
confirming the clinical studies’ results with respect to phosphene shape inconsistency across 
electrodes and subjects [74]. The approach presented here can help create a framework for 
electrode-specific optimization of stimulation parameters for the desired percept shape.  
In Chapter 4, I extended the work in Chapter 3 by utilizing the process for closed-loop 
optimization of stimulation parameters to converge to a focal RGC response in vitro. This process 
included training neural networks at each iteration based on a few images, using the interior point 
algorithm to find the optimal parameters, and classifying the resulting calcium images with a CNN 
trained on previous data. The average number of trials to converge to the most focal response was 
10 across 24 retinal regions. This means that by sampling 10 out of 46 parameter settings, the 
process can select stimulus parameters that optimize spatial activity. This approach can shorten 
the exploration time significantly compared to a manual search, especially when the parameter 
space is large. If applied clinically, patient drawings would be used in place of calcium images to 
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determine the response focality [74]. This semi-automatic approach can shorten the repetitive 
process of drawing phosphenes compared to a manual search. Previous studies have shown a 
strong correlation between two point resolution (discernibility of two distinct phosphenes) and the 
grating visual acuity task [191]. And the visual acuity is predictive of the performance on visually 
guided tasks. Thus, by creating focal, non-overlapping phosphenes, this optimization approach can 
possibly improve the outcome of artificial vision.  
In Chapter 5, I studied the effect of asymmetric anodic-first pulses on RGC thresholds. 
Whole-cell patch clamp recordings from 7 RGCs showed a decrease in thresholds with AA pulses 
with a duration ratio of 10, compared to SC and SA stimuli. This confirms our previous calcium 
imaging experiments [26], as well as human subject trials and computational modeling [188].  
6.3. Future Directions 
6.3.1. Asymmetric waveforms for retinal prostheses  
Studies in Chapter 2 and 5 demonstrate that asymmetric waveforms are effective in 
reducing retinal response thresholds. Future work should continue to explore and optimize this 
type of stimulation. For single cell recordings, RGCs should be categorized based on dendritic 
morphology, light response, and labeling, where possible. To explore the effect of anode-break 
excitation on thresholds, AA and AC stimulation thresholds with different IPGs should be 
compared. Axonal stimulation is a major concern in epiretinal stimulation [27], [74]. To study the 
effect of SA and AA pulses on axon fiber activation, axon visualization methods such as transgenic 
mice expressing enhanced Green Fluorescent Protein (GFP) or AAV injection must be used [139], 
[205]. Clinical trial results must be validated on a larger number of participants. Effect of AC 
stimulation on perception thresholds must be studied in retinal implant users. Phosphene shapes in 
response to SA and AA stimulation must be studied at various amplitudes for a more thorough 
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conclusion [26]. AA pulses with low duration ratios and long IPGs were most effective in threshold 
reduction according to our computational model. This type of pulse need to be tested on human 
subjects to verify its effectiveness. If adding an IPG to a low duration ratio AA stimulation 
maintains focal response, this pulse type can possibly offer great potential for both threshold 
reduction and creating focal percepts [26]. However, due to intrinsic variabilities between different 
retinal regions and retinal implant users, the specific stimulation parameters need to be optimized 
for each electrode. In future studies, intersubject differences such as the position of implant, 
electrode-retina distance, and the amount of retinal degeneration could be considered to explain 
percept variabilities.  
6.3.2. Automatic optimization of stimulation parameters 
Studies in Chapter 3 and 4 demonstrate a process for automatic optimization of stimulation 
parameters to produce a focal RGC response area. We only used two stimulation parameters (pulse 
amplitude and type). Other parameters, such as pulse width, IPG, and frequency could be included 
in future studies to provide a more comprehensive framework for optimization. However, having 
a large parameter space will likely increase computation time for training neural networks and 
searching for optimal parameters using the interior point algorithm. Pulse efficiency is another 
important factor that should be added to this optimization framework [140], [197], [198]. This can 
be done by selecting the most efficient of several optimal parameters for focal RGC activity, or 
modifying the objective function to include a factor for the amount of charge delivered. We used 
an in vitro retina model to simulate the response to a retinal implant. Although useful, this model 
does not fully mimic an epiretinal implant. The MEA in a human subject, as opposed to the in vitro 
MEA, is not perfectly attached to the retina due to the eye curvature. The implant can also rotate 
and reposition after the surgery [206]. This creates varying distributions of electrical field, 
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thresholds, and percept shapes with identical stimuli. Previous research studies also show that 
chronic stimulation may result in change of neural activity [207]–[209]. These factors are not 
accounted for in the in vitro retina model. In vivo retinal implant models can possibly simulate the 
retinal anatomy and pathophysiology more accurately. Functional calcium imaging of the retina 
has been realized using two-photon imaging and genetically encoded calcium indicators [210], 
[211]. Future work should also include performing human subject testing to verify the optimization 
method. Instead of calcium images, patient drawings should be used to determine the focality of 
percepts [74]. This process can be improved by a more informed selection of initial parameters 
instead of randomly selecting them.  
6.3.3. Future visual prostheses 
An ideal retinal implant should create small, round, and focal percepts for each active 
electrode in order to provide a high resolution image. I demonstrated a method for automatic 
optimization of stimulation parameters in vitro and in silico to create focal RGC activity. While 
RGC response maps are good predictors of phosphene shape, they oversimplify a more complex 
problem. The in vitro recording setup does not account for a realistic electrode-retina distance, 
response desensitization, and threshold adaptation. In addition, retinal and cortical reorganization 
can affect the spatiotemporal properties of percepts. These factors contribute to even more 
variability in spatial response, compared to the in vitro setup. Therefore, an automatic process for 
electrode-specific optimization of stimulation parameters is necessary for retinal prostheses to 
succeed. Electrode arrays with the capability to stimulate and record from the retina 
simultaneously, can possibly decrease the optimization time in clinic.  
Epiretinal prostheses should permit symmetric and asymmetric stimulation with the 
flexibility to modify pulse width and order of polarities. I showed that asymmetric pulses increase 
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the perception probability significantly compared to symmetric pulses. This effect was more 
pronounced with short pulse durations (≤ 0.12 ms) based on my RGC model. Short pulses also 
provide other advantages such as high frequency stimulation, less axonal activation, and requiring 
less charge, making it easier to remain within electrochemical safety limits. Therefore, the 
capability of generating short pulse widths with retinal implants is needed, as part of a strategy 
that provides a more flexible fitting process and improve the overall outcomes. 
Regardless of the anatomical placement, visual prostheses face similar challenges in 
capturing visual information, image processing, data and power delivery, and biocompatibility. No 
device has shown significant advantage over other systems. Resolution of artificial vision is 
limited by the electrode size and density, fading of percepts, and visual encoding processes. In 
addition, variations in disease severity, health of retinal neurons, and electrode-retina contact result 
in inconsistent outcomes. However, there has been considerable progress in the field over the past 
decades through innovation and collaboration. Some groups such as Nano Retina have focused on 
improving the electrode-retina contact by designing 3D electrodes with nano-coated tips. This may 
reduce stimulation thresholds and artifacts, but penetrating the retina might lead to greater surgical 
complications. The approaches presented in this thesis can possibly be applied to existing retinal 
implants to increase the stimulation resolution through electrode-specific optimization of 
stimulation parameters. Overall, visual prostheses hold great potential for improving vision for 
blind patients, and overcoming the limitations relies on collaborations between engineering, 
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